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Abstract

ACTION OF TYROSYL DNA PHOSPHODIESTERASE ON 3'PHOSPHOGLYCOLATE TERMINATED DNA STRAND BREAKS
Haritha Tatavarthi, MS
A thesis submitted in partial fulfillment of the requirements for the Masters Degree of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2006
Major Director: Lawrence F. Povirk, Ph. D.
Professor, Department of Pharmacology and Toxicology
Free radical-mediated DNA double strand breaks (DSBs) are induced either
directly by ionizing radiation or by certain chemicals like bleomycin. These breaks are
terminated by 3'-PG (P04CH2C00-) or 3'-phosphate groups formed as a result of
fragmentation of deoxyribose.
To study the nature of repair of these 3'-blocked breaks, we constructed substrates
mimicking fiee-radical induced DSBs. Human and yeast tyrosyl DNA-phosphodiesterase
(Tdpl) efficiently processed substrates with 3'-PGs, in either the presence or absence of
magnesium, to give a 3'-phosphate. Gel filtration chromatography and western blotting
c o d m e d that the putative enzyme in human extracts that efficiently processed PG was
indeed tyrosyl DNA-phosphodiesterase. When recombinant hTdpl was purified using
HiTrap nickel chelating columns and its PG processing activity compared to that of
partially purified native enzyme (from lyrnphoblastoid whole-cell extracts using
Sephacryl S-300 gel filtration columns), we found that the recombinant enzyme had

--

xiv

lesser 3'-PG removal activity than the partially purified native enzyme. On cloning
recombinant FLAG-tagged hTdpl into human expression vectors, we observed that the
FLAG epitope tag did not show any evidence of affecting the specificity of the enzyme.
Due to the many differences between bacterial and human cells, we cloned recombinant
FLAG-tagged hTdpl into U-87 cells (adenovirus infected glioma cell) and this
recombinant enzyme showed the same specificity toward PG substrates as when prepared
from bacteria. End-processing assays using the NHEJ proteins- Ku,DNA-PK and
XRCC41Ligase N- alone or in combination showed an inhibition of hTdpl activity on 3'overhangs. In nuclear extracts, hTdp 1 association with XRCC 1, a single-strand repair
protein, showed to increase the PG-processing activity of Tdpl up to 4 times. Whole-cell
extracts containing mutant Tdpl derived from patients suffering from spinocerebellar
axonal neuropathy (SCAN1) were found to be deficient in PG-processing. Addition of
JRLl whole-cell extract (SCAN1 extract containing mutant Tdpl) to purified FLAGtagged hTdpl showed to decrease the phosphotyrosyl processing and increase the PGprocessing of FLAG-tagged hTdpl suggesting that there must be other factors in the
extract that affect the enzyme activity.
Experiments carried out to check for the presence of Tdpl in mitochondrial extracts
obtained fromGM1310 normal human fibroblasts as well as in SCANl (JRL)
rnitochondrial extracts, showed that mitochondrial extracts contained Tdpl at a
concentration comparable to whole-cell extracts. Our results also showed that
mitochondrial extracts fiom the SCANl cell-line, JRL3 (containing mutant Tdpl), lacked
detectable Tdpl activity suggesting that all PG-processing activity in mitochondria may
be attributable to Tdpl.

Introduction

The field of cancer research is ever expanding and seems to be of pivotal
importance because man has known cancer ever since the dawn of civilization. With
increased life span of individuals, the likelihood of surviving to an age of high
susceptibilityto cancer is ever increasing, and statistically at least one in three people
develop cancer. One in four men and one in five women die fiom it. The field of
molecular biology has opened doors to genetic analysis of normal and tumor cells and
allowed us to delve into previously unapproachable questions about the molecular
mechanisms behind the development of cancer. It is these developments as well as the
quest for finding a cause and cure for the disease that has given cancer research so much
importance and attention.
Somatic mutations are the most common cause of development of cancer.
Alterations as small as single base substitutions in specific genes can cause dramatic
increases in the incidence of certain malignancies, for example colon cancer (Vogelstein
and Kinzler, 1993). However it is known that cancer is a multi-step process involving an
array of genetic alterations that come together to cause disruption of various cellular
functions, ultimately leading to the development of cancer. With as many as 10,000 DNA
lesions occurring in a metabolically active mammalian cell per day, highly discriminatory
and efficient DNA repair mechanisms have developed for its preservation (Lindahl,
1993). One of the most detrimental types of DNA damage is DNA double strand breaks
(DSBs) because they can directly disrupt the normal cellular function and survival.
Endogenous sources of DNA DSBs include disruption of DNA replication, as well as free

radicals from oxidative metabolism (Giloni et al., 1981, Hutchinson, 1985). Among DNA
damaging agents, the most significant source of DSBs is ionizing radiation (IR) such as
gamma, neutron, alpha, proton and X-radiation. DSBs of similar structure are produced
by radiomimetics such as bleomycin, neocarzinostatin, calicheamicin and esperamicin.
Bleomycin and enediyne antibiotics are called radiomimetic because their effects on cells
are similar to those caused by radiation. The formation of ionizing radiation-induced DSB
occurs mostly through excitation of a water molecule followed by its ionization into
hydrogen and hydroxyl radicals in a process also known as radiolysis of water.
1) excitation via IR: H20* H20*

2) ionization: H20*+ e + H? + OH' where e is high speed, high-energy electron

which
will interact with other atoms or electrons to
produce more radicals.
These hydroxyl fiee radicals are the most reactive ones among IR-induced free
radicals, and since the lifetime of the radicals is about 1o - seconds,
~
they will not
diffuse very far fiom the site of formation. The hydroxyl free radicals are concentrated
alongside the track of the IR beam and will target any substance nearby. They can also
react with DNA molecules in close proximity targeting mainly DNA bases and sugar
moieties.
Most of the free radical mediated DNA damage (-80%) occurs at the double
bonds of bases resulting in either 6-hydrothymine, 5-hydroxy-5,6-dihydrothymine,5hydroxymethyluracil, 5-hydroxycytosine,4,6-diamino-5-formamidopyrimidine,
8hydroxyadenine, 2,6-diamino-4-hydroxy-5-formamidopyrimidine,
thymine glycol, or

8-oxoguanine (Dizdaroglu et al., 1986). These lesions do not produce the lethality
caused by IR and can be easily repaired by base excision repair (BER). Although 8oxoguanine is a mutagenic lesion where addition of 0 on position 8 of the guanine can
mispair with A resulting in transversion, it is not considered the main cause of lethality
observed from exposure to IR. The rest of the damage caused by IR-induced hydroxyl
radicals (-20%) is on the sugar moieties through the abstraction of hydrogen atoms
from C1' to C5' of the deoxyribose. Hydrogen abstraction of hydrogen atoms fiom
these five sites of deoxyribose is a random process and leads to five possible sugar
radicals, but the main attack which produces strand breaks is on the C4' site of the
deoxyribose. This is followed by some rearrangements that result in 3'phosphoglycolate and release of base propenal. Thus, the formation of multiple SSBs
concentrated within close proximity of IR tract results in 25-50 DSBs per 1 gray (Gy)
of X-ray irradiation in a single diploid mammalian cell, which ultimately contributes to
the lethality of IR (Erixon et al., 1995).
Also, similar to IR-induced DSBs, initial attack by radiomimetics such as
bleomycin cause oxidation of C4' of the deoxyribose of the first C following a G
(Povirk, 1996). This leads to a strand break or apyrimidine (AP) site. Bleomycin is
known to be semi-sequence specific and its reactivation can lead to another attack in
the opposite strand producing a strand break or an abasic site. All breaks are blocked
by a 3'-PG and are associated with base propenal formation.

Consequences of DSBs

The presence of DSBs in a cell can be devastating for its survival if they are left
unrepaired, because many critical cellular functions such as replication and transcription
depend on the integrity of DNA. These unrepaired DSBs can result in chromosome
breaks leading to the loss of genetic material during cell division and can severely
increase the chance for oncogenic transformation or cell death (Bryant et al., 1985).
Autosomal recessive diseases such as ataxia-telangiectasia (A-T) and Nijmegen breakage
syndrome are caused by the inherent inability to protect the genome against occurrences
of DSBs, and patients with these diseases exhibit hypersensitivity to radiation, increased
oncogenic transformation, and genomic instability (Varon et al., 1998 and Waldmann et
al., 1983). Thus, the DNA DSB is thought to be the single most destructive DNA lesion.
There are other consequences to DSBs when they are inaccurately repaired. Such
consequences are deletions, f i m e shift or point mutations in addition to various
chromosomal abnormalities that may arise from misjoining of DSBs (Obe et al., 1992).
Chromosomal abnormalities including inversions, reciprocal translocations, acentric,
dicentric, ring chromosomes and other complex rearrangements have been determined to
promote global genomic instability and oncogenic transformation in mammalian cells
(Lengauer et al., 1998 and Wang et al., 1997). Consequently, mammalian cells have
acquired an ability to accurately repair DSBs through a complex network of recognition
and repair proteins.

DSB detection and signaling
Mammalian cells possess intrinsic cell-cycle signaling pathways that monitor and
respond to DNA DSBs because of the devastating consequences they bring. Until now,
most in vitro experiments regarding DSB repair have utilized naked DNA. However, in
eukaryotic cells, DNA normally exists in a compacted chromatin structure where DNA is
wrapped around two histone tetramers, H2A, H2B, H3 AND H4, into nucleosome
complexes (Laskey et al., 1980). It has been shown that when cells are irradiated with IR,
one of the histone subunits H2AX is immediately phosphorylated on a highly conserved
serine residue in the C-terminus (Mannironi et al., 1989). Also, the location of
phosphorylated H2AX was consistently coincident with the location of DSBs (Ohya et
al., 2002 and Rogaku et al., 1998). This phosphorylation is also known to induce
'opening' of the compact chromatin structure to presumably allow easier access of DSB
repair machinery to the breakage site (Downs et al., 2000). Recently, ataxia-telangiectasia
mutated (ATM) protein has been found to catalyze this critical phosphorylation (Burma et
al., 2001). ATM is the protein product of the gene mutated in the human genetic disorder
ataxia-telangiectasia, and patients who suffer from this disease exhibit neuronal
degeneration, immunodeficiency, sterility, genomic instability, radiation hypersensitivity
and predisposition to carcinogenesis. Usually, A-T patients develop lymphoma, breast
carcinoma, or leukemia during their lifetimes. These life-threatening consequences of AT are not coincidental because of the role ATM plays in not only detecting DSBs

(Anderson et al., 1993) but also in relaying this information to other cell regulatory
proteins such as p53, hCHKl and hCHK2 in order to arrest cell cycle progression at
GlIS, G2/M and intra S check points (Falck et al., 2001, Lohman et al., 2001 and Pierce

et al., 2001). ATM, which belongs to the serinelthreonine kinases of the
phosphotidylinositol3-kinase(PUK) family, is thought to be one of 'guardians of

genome' because of its important role in preventing progression of the cell cycle until
completion of DSB repair (Kim et al., 1999 and Bannister et al., 1993). Another
serinelthreonine kinase belonging to P13K family that may signal presence of DSB is
DNA-dependent protein kinase (DNA-PK), which is the gene mutated in severe
combined immune deficiency (SCID) in mice (Williams et al., 2001). In contrast to ATM,
which induces cell cycle arrest, DNA-PK may be more heavily involved in signaling
detection of DSBs to p53 dependent-apoptoticmachinery through differential
phosphorylation of p53 (Wang et al., 1997).

DSB repair pathways
DNA DSBs can be repaired through two distinct pathways: Homologous
recombination (HR) and Non-homologous end joining (NHEJ). The cell seems to choose
between these two pathways to repair the lesion and the choice primarily depends on
which phase of the cell cycle it is currently in. If the cell is in between late S and G2
phase where an intact replicate sequence is available, then HR seems to be the
predominant mode of repair. If the cell is in GOIG1 to early S phase, NHEJ appears to be
the dominant mode of repair. Yet DNA repair is not exclusive to one repair pathway.
Also, the reason NHEJ is considered to be the major pathway of DSB repair lies in the
fact that most cells in an adult organism are not continuously dividing. It is possible that

HR may be more important in stem cells that are actively dividing in the lining of the gut,
mouth, esophagus, epidermal layer of skin, and blood forming tissues, in addition to cells

with the potential to divide which include hepatocytes, fibroblasts, glandular epithelial
cells and endothelial cells.

Homologous Recombination Repair Pathway (HRR)

HRR is the predominant mode of repair in lower organisms and represents an
accurate, high fidelity pathway with no sequence loss or addition. This pathway makes
use of extensive homologies between the damaged strand and an intact homologous
strand, replacing lost nucleotides at the break site with the help of sequence information
from the undamaged strand. In HR, DSBs are introduced as an initial event followed by
resection of the DNA ends in the 5'+3'

direction. Single stranded DNA thus derived then

invades the homologous strand and DNA polymerase, which makes use of the
information from the intact DNA, fills in the gaps. Following sister-chromatid pairing and
strand invasion of DNA overhangs, HRR can go in either of two directions. Noncrossingover, resulting from disengagement of Holliday junction (a point of strand crossover)
followed by DNA pairing and gap filling in the damaged homologue, appears to be
strongly favored during HRR in mammalian cells. This is quite different from the
classical microbial pathway, in which the Holliday junctions are resolved by
endonucleolytic cleavage, with an equal probability of yielding either a crossover or a
non-crossover event. Holliday junctions are cleaved by resolvases to yield two intact
DNA strands after ligation. The yeast S. cerevisiae provides an excellent model for
understanding the biochemistry and genetics of HR. In S. cerevisiae, the -52
group of genes comprising -50-55

epistasis

and RAD57 (Game, 1993), RAD59 (Bai et al.,

1996), XRS2 (Ivanov et al., 1992) and the MREll/RAD58 genes carries out HR

(Baurnann and West, 1998). After DSB induction, Rad52 binds to the broken DNA ends
in order to protect them from exonucleolytic degradation. Resection of the DNA from
5'33' is possibly through the coordination of the RadSO/Mrell/Xrs2 (Xrs2 is the yeast
homologue of human NBS) complex. Evidence suggests that the MRN complex
functions in NHEJ as well. The Rad5O binds to DNA in an ATP-dependent manner
(Raymond et al., 1993). The Mrel 1 protein has an exonuclease function that is active in
the 3'+ 5' direction on the ss- and ds-DNA with a preference for recessed 3' ends
(Shinohara et al., 1992). It also has an endonuclease function critical in meiosis. Next in

HR, Rad5 1 polymerizes on ss and ds-DNA forming filaments and mediates strand
invasion in the 3'+ 5' direction (Sung et al., 1994). The human Rad5 1 protein is also
homologous to the E.coli RecA protein. Strand exchange is stimulated by the addition of
RPA (Sugiyama et al., 1997).

BRCAl and BRCA2 are two breast cancer susceptibility genes recently shown to
be linked with DNA repair by virtue of their BRCT domains, which are a common
feature of DNA repair proteins (Callebaut et al., 1997). Both proteins interact with Rad5 1
and co-localize to nuclear foci in response to DNA damage in mitotic cells (Scully et al.,
1997). Recently, it was demonstrated that BRCA2 interacts with RADSl and RPA at the
site of DSB and helps load RAD5 1 onto DNA or to organize RAD5 1 filaments (Yang et
al., 2002). Disruption of BRCA2 gene by targeted truncation in mice makes cells from
them sensitive to UV light and methyl methane sulfonate. The cells arrest in G1 and
G2/M phases and increased levels of p53 and p21 accompany this arrest (Pate1 et al.,
1998). Mouse fibroblasts with BRCA1-1- and BRCA2-1- status develop spontaneous
chromosomal aberrations, providing further evidence for the role of these proteins in

HRR (Pate1 et al., 1998). Altogether, BRCAl and BRCA2 are believed to be important at
early points of HRR and perhaps coordinate repair with other cellular processes.
Attempts to assess the biological consequences of defects in specific HRR factors
have been hampered by the embryonic lethality of many mouse knockouts targeting genes
involved in HRR. RAD54 knockout mice are viable, and embryonic fibroblasts of HRRdefective RAD54 knockout mice are radiosensitive (Essers et al., 1997,2000). RAD54
deficiency does not confer radiosensitivity in otherwise normal adult mice, but futher
enhances the radiosensitivity of NHEJ-deficient Scid mice (with a mutation in DNAPKcs). These results suggest that HRR may be a more important repair component in
embryonic cells than in normal adult somatic cells. Studies of both knockout mice and
repair-deficient cultured cells suggest that disruption of any factor involved in HRR
results in chromosomal instability and (for those defects that are not lethal) cancer
predisposition (Thompson and Schild, 2001; van Gent et al., 2001).

Non-Homologous End-Joining Pathway

This is the second major pathway of DSB repair and is the predominant
mechanism of repair in mammalian somatic cells. The term "non-homologous" is used to
indicate the fact that this pathway does not require extensive homologies between two
DNA strands to be recombined (Roth et al., 1985), although micro homologies of as little

as 1-5 base pairs are often used (Labhart, 1999; Critchlow and Jackson, 1998). A
deficiency in this pathway leads to a myriad of consequences like radio-sensitization,
increased susceptibility to development of cancer and a variety of immunodeficiency
syndromes, most if not all of which are due to the defect in the repair of DSBs. Over

more than a decade, genetic and biochemical approaches have now identified the major
proteins that play a crucial role in this repair process. NHEJ involves a DNA-binding
heterodimer of Ku70 and Ku80 proteins, which associates with the catalytic subunit of
DNA-dependent protein kinase (DNA-PKcs) to form DNA-PK holoenzyme. Additional
factors include DNA ligase N,its cofactor XRCC4 and probably DNA polymerase h
and/or human polynucleotide kinaselphosphatase or hPNKP (Critchlow and Jackson,
1998; Jackson and Jeggo, 1995; Chu, 1997). Ku was first identified as an autoantigen for
a number of autoimmune diseases in 1981, but Rathrnell et a1 linked it to NHEJ when
they observed that Ku complementation conferred X-ray resistance to X-ray sensitive
hamster cell line, xrs5. Subsequently, several X-ray cross complementation (XRCC)
genes were identified by virtue of their ability to correct radiation hypersensitivity in
rodent cell lines. They are XRCC4, XRCCS, XRCC6 and XRCC7 encoding the proteins
XRCC4, Ku86, Ku70 and DNA-PKcs respectively. With these discoveries, a host of
other genes that are now known to be integral players in recognition, signaling, and repair
of DSBs have begun to emerge. And the list is increasing at an extraordinary pace
implicating additional factors such as hMrel 1, hRad50, Nbsl, APE1, Artemis and
Werner, as well as many additional proteins involved in downstream signaling.

Structural and biochemical properties of end-joining proteins

Ku Heterodimer
As subunits of DNA-dependent protein kinase, Ku70 and Ku86 are proteins with

molecular weights of 70 and 86 kDa respectively. This Ku heterodimer forms a closefitting asymmetrical ring that threads onto a free end of DNA as a "nut on a bolt" (Walker

et al., 2001). Also, using nitrocellulose filter-binding assay, its affinity toward dsDNA has
been determined to be much higher than toward ssDNA (Walker et al., 2001). The
dissociation constant of Ku towards ds DNA is in the range of 1-2 nM while that for
single-stranded DNA is about 300nM (Tuteja and Tuteja, et al., 1994). Later studies
showed that Ku can also bind to gapped and nicked DNA as well as to DNA hairpins
such as those generated during V(D)J recombination (Blier et al., 1993; Falzon et al.,
1993). Although Ku tends to cling to the DNA end, it can translocate into the interior,
allowing multiple Ku heterodimers to load onto longer DNA molecules (Mimori et al.,
1986; Yaneva et al., 1997). The end-bound Ku occupies approximately 16-1Sbp, as
indicated by X-ray crystallography, DNase footprinting (Lee et al., 2004) and ultraviolet
crosslinking (Walker et al., 2001). The primary h c t i o n of Ku70186 in NHEJ, which is
alignment of two DSB ends for subsequent repair processes to ensue, has been suggested
fiom their ability to self-associate. In order to bind to DNA, both subunits of Ku should
be present and interact with each other (Griffith et al., 1992). Also, in a DNA sequenceindependent manner, the self-association of Ku molecules that form either DNA loops
(intramolecular interaction) or DNA intermolecular bridges has been observed through
atomic force microscopy (Cary et al., 1997). In addition to acting as a DSB alignment
factor, Ku recruits DNA-PKcs molecules to DSB ends and forms a stable complex while
stimulating its kinase activities (Dvir et al., 1992; Gottlieb and Jackson, 1993). It is also
known to stimulate the catalytic activities of DNA ligase IV (Cary et al., 1997). A search
for homology between the cDNAs of the 2 subunits of Ku led to the identification of
leucine zipper motifs (Wu and Lieber, 1996) which suggested a role for Ku in regulation
of transcription and ATP binding domains in both Ku70 and Ku80 which were thought to

be essential for ATPase function of Ku (Cao et al., 1994). In addition to the ATPase, Ku
was reported to unwind duplex DNA and was thus classified as human DNA helicase IT
(Tuteja et al., 1994). It unwinds DNA duplexes in a 3'+ 5' direction on the bound strand.
The ATPase function is attributed to both the subunits whereas the helicase is entirely a
function of Ku70 (Ochern et al., 1997).

DNA-PKcs
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the largest
component of the DNA-PK holoenzyme. It is a -460 kDa serinelthreonine kinase that
belongs to the subgroup of PIK-related kinases within the phosphatidylinositol (PI)-3
kinase superfamily (Hartley et al., 1995). All the members of this subgroup have a 3'
conserved kinase domain similar to the lipid kinases, but in addition also have another
conserved domain 3' to the kinase domain. DNA-PK was purified from Hela nuclear
extracts as a protein that was able to phosphorylate DNA binding proteins like p53, SV40
large T antigen and Ku (Carter et al., 1990; Jackson et al., 1990; Lees-Miller et al., 1990).
Monoclonal antibodies against the 460 kDa kinase specifically inhibited the kinase
activity from the cell extracts. Immunodepletion of the protein also abolished the kinase
activity (Carter et al., 1990). Two smaller polypeptides were also isolated with the 460
kDa DNA-PK and sequence analysis revealed that they were in fact the 2 subunits of Ku
that co-purified with DNA-PK (Lees-Miller et al., 1990). Subsequent studies showed that
DNA-PK binds to and is activated by binding to dsDNA ends (Gottlieb and Jackson,
1993). They also showed that when Ku was mixed with the 460 kDa protein fractions, it
stimulated the kinase activity of those fractions. Pre-incubating cell extracts with anti-Ku
antibodies abolished the kinase activity. All these observations suggested that Ku was a

component of DNA-PK and was required for dsDNA dependent stimulation of DNA-PK.
However, this is not true in its entirety because it was later shown that DNA-PK is not
activated by many substrates that are efficiently bound by Ku like hairpins, nicks (Smider
et al., 1994) and cis-platin cross-linked DNA (Turchi et al., 2000). Furthermore, DNAPKcs can be activated in the absence of Ku as long as the concentration of DNA ends is
sufficiently high and ionic strength sufficiently low to support DNA-PKcs binding to the
DNA ends (Hammarsten and Chu, 1998). This suggested that DNA-PKcs was activated
by its direct interaction with dsDNA and that Ku was needed just to stabilize this binding.
An electron crystallography study revealed that the DNA-PKcs structure contains and

open channel, and an enclosed cavity with three openings large enough to allow the
binding of a single-stranded DNA (Leuther et al., 1999). The results from ultraviolet
crosslinking studies suggest that, when a DNA-PKcs molecule binds a DNA terminus, it
displaces Ku approximately10 bp interior away fiom the terminus (Yoo and Dynan,
1999). Formation of the DNA-PK holoenzyrne complex (Ku and DNA-PKcs) on a DNA
end results in the activation of its kinase activity (Smith and Jackson, 1999). Studies with
various oligomeric substrates suggest that activation involves insertion of a few bases of
the single strands into defined channels (Hammarsten and Chu, 1998). Activation is
relatively insensitive to structural modifications in these single strands, suggesting that
even severely damaged termini could still activate DNA-PK (Weinfeld et al., 1997;
Martensson and Hammarsten, 2002).
Activated DNA-PK phosphorylates a variety of DNA-binding proteins (Anderson
and Lees-Miller, 1992), including several with known or putative roles in end-joining
such as Ku (Lees-Miller et al., 1990), XRCC4 (Leber et al., 1998), Werner (Yannone et

al., 2001) and the Artemis nuclease (Ma et al., 2002). Activated DNA-PK also
phosphorylates itself, resulting in its dissociation from DNA (Chan and Lees-Miller,
1996). Pharmacological inhibitors of PI-3 kinase family can also regulate DNA-PK
activity. Wortmanin, a sterol-like fungal metabolite, is one such potent and selective
inhibitor of mammalian PI-3 kinases (Ui et al.,1995; Powis et al., 1994). A detailed
kinetic analysis of wortmanin mediated DNA-PK inhibition showed that wortmanin
inhibits DNA-PK in a non-competitive manner with a Ki of 120nM (Izzard et al., 1999).
The compound forms a covalent bond with the kinase domain of DNA-PKcs in vivo and
in vitro and this binding is not dependent on presence of Ku (Izzard et al., 1999).

LY294002 is another potent inhibitor of DNA-PK and other PI-3 kinases (Rosenzweig et
al., 1997) LY294002 also sensitizes human tumor cells to IR at the same concentration
required to inhibit DNA-PK activity.
XRCCW DNA Ligase IV
The XRCC4 gene was originally isolated by complementation of radiosensitivity,
V(D)J recombination deficiency and DSB repair deficiency of the radiosensitive CHO
derivative XR-1 (Li et al., 1995). As revealed by X-ray crystallography, XRCC4 consists
of a globular head plus a long a-helical tail. In the crystal, four XRCC4 monomers form a
dumbbell shaped homotetramer with two globular heads at each end and the ends linked
by the four interacting tails (Junop et al., 2000). In cells, DNA ligase IV is present in a
tight complex with XRCC4 and the complex can withstand buffer conditions of 2 M
NaCl or 7 M urea (Lee et al., 2000). Ligase IV is not detectable in cells lacking XRCC4,
but XRCC4 is stable by itself (Bryans et al., 1999). Ligase IV binds to XRCC4 at a site
near the middle of the a-helical tail. A unique characteristic of DNA ligase IV is a large

C-terminal region containing tandem repeats of BRCT domain, a motif commonly found
in proteins involved in DNA repair and DNA damage signaling, which is also responsible
for interacting with XRCC4 (Sibanda et al., 2001). In addition, it is the only DNA ligase
that is able to maintain its catalytic activity in low magnesium concentration such as in 1

mM. The role of XRCC4lDNA ligase IV in NHEJ has been extensively investigated
through its interaction with other proteins of the NHEJ machinery. Electrophoretic
mobility shift assay and immune-precipitation show that Ku physically interacts with the
complex and recruits it to DNA (McElhinny et al., 2000). The interaction of
XRCC4Aigase IV with DNA is stabilized only in the presence of Ku, but DNA is not
required for the interaction of Ku with the complex. Chen et al., in 2002, found that under
their experimental conditions, Ku actually inhibits intramolecular ligation by
XRCC4Aigase IV suggesting that this complex is rather complex. XRCC4 also interacts
with DNA-PKcs and is an effective substrate for phosphorylation by DNA-PKcs, but the
relevance of this phosphorylation to NHEJ is still unclear. Phosphorylation occurs on
serine and threonine residues in the carboxy-terminal of the protein (Leber et al., 1998).

Oxidative Stress and DSBs

Oxidative stress plays a major role in aging and in many human diseases,
including cancer and various neurological disorders (Lu et al., 2004). The primary known
targets of oxidative damage are cell membranes and DNA. Ionizing radiation,
radiomimetic drugs, and to some extent, all fiee radical based genotoxins induce DNA
DSBs either by base release or oxidative fragmentation of DNA sugars (Inamdar et al.,
2002). In particular, oxidation of the C-4' position results in breaks with 5'-P and 3'-PG
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termini. Repair of such breaks requires the conversion of these modified 3' termini to 3'
hydroxyls, so that DNA polyrnerases can replace the missing nucleotide and DNA ligase
can seal the nick. At single-strand breaks in double-stranded DNA, conversion of both 3'P and 3'PG termini to 3'-hydroxyl termini were found to be catalyzed by the human basic
endonuclease, Apel '(Suh et al., 1997). However, 3'-PG termini in single-stranded
segments of DNA, such as 3' overhangs of DNA DSBs, are completely refractory to Apel
(Chaudhry et al., 1999). The human polynucleotide kinaselphosphatase PNKP, which
removes 3'-P from single-stranded 3' termini, also has no detectable effect on 3'-PGs
(Jilani et al., 1999; Karimi-Busheri et al., 1999) and this is similar to reports for rat PNKP
(Habraken and Verly, 1988). The susceptibilityof 3'-PGs to E. coli exonuclease I
(Sandigursky and Franklin, 1993) raised the possibility that PGs on 3' overhangs might be
removed by a mammalian 3 ' 3 5' exonuclease. However, DNase III,which is the
dominant 3 ' 3 5' exonuclease in mammalian cell extracts, has no detectable effect on any
3'-PG substrates (Inamdar et al., 2002). The Wml and Mrel 1 3'+ 5' exonucleases are
also unlikely candidates to these enzymes (Kamath-Leob et al., 1998; Huang et al., 2002).
Nevertheless, it was shown that Xenopus, human and hamster whole cell extracts possess
potent activity for processing of PGs on single-stranded 3'overhangs of DSBs, as well as
from simple single-stranded oligomers (Chen et al., 2001).
Tvrosvl DNA phosphodiesterase
Topoisomerases are essential ubiquitous cellular enzymes required to control the
superhelical tension and DNA entanglement associated with DNA replication,
recombination, transcription and chromosome segregation (Connelly and Leach, 2004). In

-

--\

eukaryotes, topoisomerase I transiently breaks one strand of DNA, forming a covalent
linkage between the side chain of its active site tyrosine and a 3' P of DNA, subsequently
reversing it to re-ligate the DNA. Although this activity is essential for survival,
topoisomerase I can be toxic. When the enzyme cleaves DNA at or near a variety of DNA
lesions, the re-ligation step is hindered and topoisomearse I remains on the DNA as a
covalent 'cleavable complex'. The initial DNA lesion is thereby transformed unto a
single-strand break that is encumbered with a protein adduct. Cleavable complex
formation is also induced by chemotherapeutic agents, such as captothecin (CPT), that
specifically inhibit topoisomerase I re-ligation. An encounter with a replication fork
converts the cleavable complex into a potentially lethal DSB. Tyrosyl DNA
phosphodiesterase 1 (Tdpl) was first isolated from Sacchromyces cerevisiae as an
enzymatic activity that precisely cleaves this tyrosyl-phosphodiesterbond linking tyrosine
of topoisomerase I to a 3' DNA end (Yang et al., 1996). Subsequently the S.cerevisiae
gene for Tdpl was cloned and characterized, and orthologs were identified in other
eukaryotic but not prokaryotic species.
Previous experiments in yeast presented two lines of evidence showing that Tdpl
is a repair protein that only acts after the occurrence of a DSB. First, biochemical studies
with highly purified Tdpl showed that the enzyme is most active on substrates that mimic
DNA that has a topoisonierase I-linked DSB and is less active on a substrate that
resembles an unprocessed cleavable complex. Second, an analysis of the phenotype of
single and double mutants shows that the in vivo repair of topoisomerase I lesions by
Tdpl depend on the function of the RAD52 gene, which is known to be vital for DSB
repair. Taken together, these results for the first time placed tdpl in a RAD.52-dependent

DSB repair pathway. Surprisingly, a S.cerevisiae strain containing a null mutation in the
tdpl gene is no more sensitive to CPT killing than the wild-type strain. However, when

the tdpl null mutation of S. cerevisiae was added to a rad9 mutation there was a 10-fold
increase in the lethal effects of CPT, suggesting that there are other, Tdpl -independent,
pathways of repair. The RAD9 gene is vital for the function of a DNA damage
checkpoint. Since it is also critical for DNA damage-induced expression and the posttranslational modification of several genes, it is possible that an important component of
the Tdpl -independent pathway might be limiting in a rad9 strain. Subsequent genetic
studies in yeast have revealed at least two other separate pathways that can contribute to
the repair of topoisomerase I-DNA covalent complexes. These include the structurespecific endonucleases RadllRad10 and Mus8 1M s 4 . Deletion of the MUS81 confers
sensitivity to CPT apparently through a pathway parallel to Tdpl and Radl as the triple
mutant tdpl radl mus81 is more sensitive than the double-mutant tdpl radl.
Experiments using a genome wide screen to detect all non-essential genes that are
important for protection fiom growth inhibition or killing produced by continuous
exposure to CPT helped identify two further pathways involved in repairing the ToplDNA complex, one involving S1x4 which acts in a parallel pathway to Tdpl and
RadlIRadlO, and Sae2 which appears to act by stimulating the endonulcease activity of
Mrel 1.
Evidence for a 3'-P intermediate in 3'-PG removal in human cell extracts
suggested possible involvement of hTdpl, and indeed, both hTdpl and yTdpl were found
to catalyze similar glycolate removal from a single-stranded oligomer as well as fiom a
single strand overhang of a DSB (Inamdar et al., 2002). Yeast and human Tdpl differ

from other activities for processing blocked 3' ends in that they leave behind a 3'-P rather
than a 3'-hydroxyl. The 3'-P can then be removed by PNKP (Jilani et al., 1999; KarimiBusheri et al., 1999).
The exact step of NHEJ at which Tdpl acts is yet unknown. Kinetic studies show
that at least in extracts, much of the PG removal from 3' overhangs occurs within the first
few minutes, suggesting that it does not require the formation of the full repair complex
(Inarndar et al., 2002). Indeed, the kinetic data suggest that as the ends become
sequestered by DNA-PIS, PG-removal is dramatically suppressed, raising the possibility
that there maybe additional 3'-PG processing enzymes that act in context of the repair
complex.
Tdpl is a member of the phospholipase D superfamily

The members of the PLD superfamily comprise a highly diverse group of proteins
that include plant, mammalian and bacterial PLDs, bacterial phosphatidyl-serine and
cardiolipin synthases, a bacterial toxin, several pox-virus envelope proteins, and some
bacterial nucleases.
Recent database searches revealed a hll-length human cDNA encoding a 608-aa
Tdpl ortholog (68.5 kDa) located on chromosome 14. Predicted Tdpl orthologs are
present in a number of other eukaryotic organisms. The homology between the Tdpl
orthologs from different species extends from approximately amino acid 150 of the
human protein to the C terminus. The N-terminal regions of the Tdpl orthologs are
poorly conserved and vary substantially in length. Among the regions that are best
conserved are amino acids 262-289 and 492-522 of the human protein. A sequence
alignment of these conserved regions with motifs 3 and 4 of representative members of

each class within the PLD superfamily reveals a high degree of similarity. Importantly,
motifs 3 and 4 encompass the highly conserved HKD sequence identified as a hallmark of
the PLD superfamily. In both Tdpl and the members of the PLD superfamily, the
conserved histidines, lysines, and aspartic acidss that form the HKD motif, surround the
active site pocket. However, a conserved aspartate, positioned a long way from the active
site and important for protein folding and stability, is present only in the PLD superfamily
members and not Tdpl. Furthermore, the remainder of the human Tdpl protein sequence
cannot be reasonably aligned with any of the other PLD family members. Based on these
findings, it was indicated that the Tdpl orthologs represent a distinct class within the
PLD superfamily.
As a member of the PLD superfamily, human Tdpl is predicted to require a

combination of two histidines (H263 and H493) and two lysines (IS265 and K495) for
catalytic activity. Biochemical experiments and the crystal structure of human Tdpl
confirm this prediction and demonstrate that the reaction proceeds through an
intermediate in which the active site H263 is covalently bound through a phosphoamide
bond to the 3' end of the DNA moiety of the substrate. In the second step of the reaction,
hydrolysis of the covalent intermediate yields the DNA product and frees the enzyme.

Substrate specificity of Tdpl
Role of Tdpl in SSB repair
DNA SSB repair is critical for the survival and genetic stability of mammalian
cells. SSBs can arise either directly (e.g., from attack of deoxyribose by free radicals such
as ROS) or indirectly (via enzymatic cleavage of the phosphodiester backbone, e.g., as

normal intermediates of DNA BER). SSB repair can be divided into four basic steps,
beginning with DNA damage binding. The second step in SSB repair is DNA end
processing followed by DNA gap filling. In the final step, the integrity of the
phosphodiester backbone is restored by DNA ligation.

In yeast, Tdpl has been implicated in the repair of topoisomerase I-DNA adducts
via the DSB repair pathway, although it is also clear that additional Tdpl -independent
repair pathways can also correct topoisomerase I-mediated lesions. However, the role of
Tdpl in mammalian cells is not well understood. Its role in SSB repair is controversial.
Early papers have proposed that Tdpl participates in SSB repair. In humans, a mutation
that inactivates Tdpl in vitro is associated with inherited Spinocerebellar ataxia with
axonal neuropathy or SCAN1. This result was initially surprising since DSBs form as a
result of DNA replication in yeast and the inability to repair topoisomerase I-DNA
adducts should not preferentially affect non-dividing neuronal cells. This observation
therefore led to the proposition that Tdpl acts via a SS repair pathway since SSBs can
result from the collision of transcription complexes with abortive topoisomerase I-DNA
adducts. A variety of recent observations have also been used to argue that SSB repair
pathways are the preferred routes for repairing topoisomerase I-cleavage complexes in
mammalian cells. First, cells containing inactive SSB repair proteins and XRCCl are
hypersensitive to CPT. In addition, yeast two-hybrid experiments revealed that Tdpl
associates with the SSB repair machinery by direct interaction with DNA ligase ma,a
partner of XRCC1, a scaffold for repair proteins involved in SSB repair in higher
eukaryotes. This might account for the observation that Tdpl co-immunoprecipitates with
XRCC1. Based on this result, it has been proposed that XRCCl DNA repair complexes

contain enzymes required to excise the topoisomerase I-DNA adduct (Tdpl), process the
DNA strand (PNKP), replace the missing DNA segment (P-polymerase), and seal the
DNA in the absence of a DSB (ligase m). Therefore, one would expect the nicked or
tailed substrate (mimicking a gapped DNA duplex) to be good substrates for Tdpl .
Recently, Raymond et al. (2005) presented results showing that Tdpl does not
have a kinetic or binding preference for single strand DNA over blunt end duplex DNA.
The paper suggested that both single strand and double stranded blunt DNA substrates
over nicked or tailed substrates. It
have significantlyhigher specificity constants (kat/KM)
was also shown that Tdpl binds single stranded and double blunt stranded substrates with
significantly higher affinity (lower KD)than with nicked or tailed substrates. Because
single stranded DNA is not expected to be a common substrate in vivo, the authors
proposed that double stranded blunt DNA is the natural substrate in vivo. If this is the
case, these studies clearly suggest that Tdpl acts after the topoisomerase I-mediated
damage is converted to a DSB.
Proposed mechanism of action of Tdpl
SCAN1

The association of human genetic disorders with defects in the DNA damage
response is well established. Most of the major DNA repair pathways are represented by
diseases in which that pathway is absent or impaired. Hereditary ataxia comprises a
clinically and genetically heterogeneous group of diseases that include disorders in DNA
repair, such as AT, XP and Cockayne syndrome. In contrast to the isolated forms of
hereditary ataxia, disorders of DNA repair typically cause additional syniptoms, such as
mental retardation, photosensitivity, immunodeficiency and neoplasia. A homozygous

recessive mutation in the human TDPl gene (A1478G) that results in the substitution of
H493 with an arginine residue was found to be responsible for the human hereditary
disorder SCANl. The ataxia first becomes noticeable in the teenage years and apparently
results from an effect on non-dividing terminally differentiated neuronal cells. SCANl is
characterized by peripheral axonal motor and sensory neuropathy, distal muscular
atrophy, and steppage gait. The association of a DNA repair protein with SCANl is
striking, in that this is a neuro-degenerative disease that lacks any obvious
extraneurological features such as genetic instability or cancer.
The A1478G mutation was originally proposed to be a loss of function mutation
but a recent paper (Interthal et al., 2005) has suggested that the H493R mutation reduces
the activity of the enzyme only -25-fold based on the rate of product formation by the
purified enzyme. This small amount of residual activity maybe sufficient to provide most
of the repair capacity required throughout the life of an individual and thus explains the
late onset of the disease in SCANl individuals. Alternatively, similar to yeast, there
maybe a functional overlap of other repair systems so that, in the absence of sufficient
Tdpl activity, other pathways capable of repairing topoisomerase-I DNA covalent
complexes fulfill the needs of the organism.
It is not known yet whether a SSB repair process or a DSB repair process
is defective in SCAN1.Quantitative y-H2AX irnmunostaining and neutral comet assays to
examine whether the breaks that accumulate in SCANl cells are SSBs or DSBs, were
carried out. Neither assay revealed a measurable difference between the level of DSBs in
non-replicating normal and SCANl cells. Consequently, it was assumed that since both
assays can detect as little as 1-2 Gy equivalents of DSBs, more than 98% of the breaks

that accumulate in non-replicating SCANl cells are SSBs. But at the same time, there
have been suggestions of XRCC1 involvement in DSB repair pathway. A protein partner
of XRCC1, PAW-1, binds both SSBs and DSBs, and in NHEJ defective background, the
additional disruption of PAW-I results in embryonic lethality. This has raised the
possibility that PARP-1 iiilfills a back up role during DSB repair, by binding and
recruiting XRCC1 and other SSB repair proteins to DSBs that are not repaired by
classical NHEJ.
It remains unclear why neurons are specifically affected by the Tdp 1 defect in
SCANl individuals. One possibility is that the elevated oxidative stress in post-mitotic
neurons creates a particularly high level of SSBs. In addition, the limited regenerative
capacity of the nervous system might render this tissue particularly susceptible to cell
loss. Another possibility might be that unrepaired SSBs can be processed by HR, in
proliferating cells, even in the absence of Tdpl, once they have been converted to DSBs
during DNA replication, as in budding yeast. Terminally differentiated neurons have an
enhanced need for Tdpl -mediated repair or are hypersensitive to the effects of persistent
topoisomerase I-DNA covalent complexes, perhaps because alternative pathways may be
attenuated in differentiated neurons. Interestingly, CPT was shown to induce apoptotic
cell death in post-mitotic cortical neurons, indicating an important replicationindependent role for topoisomearse I in this cell type.
Other roles of Tdpl

Tdpl may also have multiple roles in the cell. For example in Drosophila, Tdpl
has been shown to be essential for the formation of epithelial polarity and for neuronal
development during embryogenesis, and it has been proposed that Tdpl is involved in the

localization of membrane proteins (Dunlop et al., 2004). Although no substrate or
mechanism has been proposed to support this function, Tdpl is a member of the PLD
superfamily of enzymes (Interthal et al., 2001) and other members of this superfamily
participate in membrane vesicle trafficking by hydrolyzing phosphatidylcholine to
generate phosphatidic acid (Hughes et al., 2004; Humeau et al., 2001). These results
emphasize the importance of understanding the in vitro binding properties and catalytic
mechanism of Tdpl to better understand its biological role(s).

Materials and Methods

Polyacrylamide gel electrophoresis
For denaturing gels, 8 M urea solution containing 20: 1 acrylamide: bisacrylarnide
solution was prepared. Urea was allowed to dissolve at low heat and the mixture was then
allowed to cool to room temperature. Polymerization was initiated by addition of 0.075%
(w/v) arnmonium persulfate and further accelerated with 0.03%(v/v) TEMED (N', N',
N', N'-tetra methylethylene). The gel was allowed to set for

- lhour after which samples

were loaded onto the gel and electrophoresed at a constant power of 40 to 50 watts
depending on the size of the gel for 3 to 6 hours respectively. For end-processing assays,
the gel was frozen and exposed on PhosphorImager screens for 1-2 days at -20' C.
Phosphor images were analyzed and bands were quantified using ImageQuant software
(Molecular Dynamics). For labeling of oligonucleotides with 3 2 ~the
, gel was exposed to
X-ray film for approximately 30 seconds to 1 minute. The film was transilluminated
against white light and the bands on the film were lined up with the gel. The part of the
gel corresponding to the bands was cut and placed in 6 mL of 0.3 M sodium acetate/ 1

mM EDTA and allowed to elute at room temperature over night. On the second day, the
elute was removed, divided into 1 mL eppendorf tubes and vacuum dried until all the
liquid evaporated and left behind a white residue. The residue was dissolved in 800 pL of
deionized water and mixed with 800 pL of 0.2 M triethylamine. The oligonucleotides
were then subjected to high-pressure liquid chromatography (HPLC).

High-pressure liquid chromatography (HPLC)

DNA oligonucleotideswere purified by the use of reverse phase high pressure
liquid chromatography (HPLC). Reverse phase means that the gradient starts with a more
aqueous mobile phase and progresses to a more hydrophobic mobile phase.
Chromatography was carried out using a Rainin 5 p.M Microsorb C18column and 2
buffers, buffer A (5 % acetonitrile, 0.1 M triethylammonium acetate pH 7) and buffer B
(50% acetonitrile, 0.1 M triethylammonium acetate pH 7). Glacial acetic acid was used to
adjust the pH of the buffers while the use of NaOH was prohibited to avoid salt build up
in the column. DNA interacts with column via the triethylamine present in the buffer. The
negative charges of the DNA phosphate backbone are attracted to positively charged
mine groups. Furthermore, the ethylene groups of triethylamine mediate interactions
with the carbon chains. This DNA-triethylamine- CI8column interaction is hindered as
the acetonitrile concentration is increased through a computer-controlled gradient directly
competing for triethylamine until the DNA is eluted. First, the column was flushed with
buffer B for 10 min to expel any residues fiom previous use. Then, the column was
flushed with buffer A for 10 min. Next, the linear gradient was activated which mainly
hctions to increase the mobile phase acetonitrile percentage fiom 5% to 30% over 60
min by controlling the buffer flow fiom buffer A and B. the DNA oligo sample dissolved
in 0.1 M triethylamine to a volume of 800 pL was injected into the sample loading port.
With a flow-rate of 1 mumin, the content of the effluent was monitered by a
photomultiplier-tube detector and was recorded on the polygraph. After 20 to 30 min, the
oligonucleotides eluted and the elute was vacuum dried for approximately 4 to 6 hours.

After the oligo was completely dried, it was resuspended in TE buffer (10 rnM Tris-HC1
pH 8,O.l mM EDTA).

Whole-cell extract preparation from human lymphoblastoid cells (GM0058B)

The procedure described by West and Bawnann, 1998, PNAS was used. Cell lines
were purchased from NIGMS Human Genetic Mutant Cell Repsotiory (Camden, NJ).
GM0058B was a normal transformed cell line fiom a young 26-year old Caucasian. Cells
were cultured in suspension in Rosewell Park institute medium (RPMI 1640) with 10%
fetal calf serum (FCS) and allowed to grow to a density of 8 x 10' cells/ml before
harvesting. They were then washed once in RPMI 1640 containing 10% FCS and once in
ice-cold phosphate buffered saline (PBS) before transporting to the laboratory for extract
preparation. Cells were received re-suspended in 200 ml of RPMI 1640. A sterile
centrifuge bottle was weighed and the cells were transferred to the bottle and spun down
at 1200 rpm for 10 minutes in the SS34 rotor. The cell pellet was re-suspended in 200 ml
of ice-cold PBS and washed two times. PBS was then discarded and the cells were
washed with hypotonic lysis buffer containing 10 rnM Tris-HC1, ph 8.01 1 mM EDTAI 5

rnM Dm. A 2 ml pellet was obtained at the end of the final wash, which was the resuspended in 2 volumes (4 ml) of hypotonic lysis buffer again. Cells were allowed to
swell for about 20 minutes on ice after which they were transferred to a 7 ml tissue
homogenizer and cells were lysed with 20 stokes of pestle "A". The following protease
inhibitors were added in appropriate concentrations-phenylmethylsulfonyl fluoride, 0.17
mgtml; aprotinin, 0.01 trypsin inhibitors units1 ml; leupeptin, 1 Wml; pepstatin, 1 pgml
and chymostatin 1 pglml. The homogenizer with the lysed cells was put on ice for 20

minutes. After 20 minutes, the lysate was transferred to a 50 ml centrifuge tube and 0.5
volumes (3 ml) of high salt buffer (50 mM Tris-HC1, pH 7.51 1 M KC11 2 mM EDTAf 2

mM DTT) was added. The total 9 ml volume was then subjected to high-speed
centrifugation. A Beckman SW 50.1 rotor with six-buckets was used. The initial weight
of the buckets was noted down. The extract was divided into equal volumes and
transferred to Beckrnan centrifuge tubes. The buckets were weighed again after placing
the tubes in them. The weight of each bucket was balanced against each other to within
0.001 g. the buckets were then transferred to a Beckrnan ultracentrifuge, which was precooled to 4OC before putting the buckets in. the extract was then centrifuged for 3 hours
at 42000 rpm. After 3 hours, the SW 50.1 rotor was removed and the contents showed
three distinct layers; a top layer of cellular fat, the second layer of clear supernatant and
the third layer of cell debris. The clear supernatant was carefully aspirated out using a 20

G hypodermic needle and a 3 ml syringe. The extract was then transferred to a pre-treated
dialysis tubing of M.W. exclusion range between 6000-8000 Dalton and dialyzed for 3
hours in a buffer containing 20 mM Tris-HC1, pH 8.01 0.1 M potassium acetate1 20%
(vlv) glycerol1 0.5 rriM EDTAI 1 rnM DTT. The dialyzed extract was then divided into 50
and 100 pl aliquots and transferred to cryo-freeze vials, flash fiozen and stored at -70°C
until further use. Protein concentration of the extract was determined using the Lowry
protein assay. For each batch of extract, an

- 10-12 mglml protein concentration was

obtained.

Purification of DNA from non-competent cells using QIAamp DNA Minikit

6 ml LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaC1, 1N NaOH,
1M MgS04 and 1% glucose) containing 25 mglml ampicillin with plasmid containing
E.coli bacterial colony was incubated overnight at 37OC. Bacteria were then pelleted by
centrifugation for 10 minutes at 8000 rpm. The bacterial pellet was resuspended in 180 pl
ATL buffer to which 20 pl Proteinase K was mixed by vortexing. The mixture was
incubated at 56OC in a shaking water bath for 2 hours or until the tissue is completely
lysed. The microcentrifuge tube was briefly centrifuged to remove drops from the inside
of the lid. 4 pl of 100 mg/ml Rnase A was added and the mixture was mixed by pulsevortexing for 15 seconds and then incubated for 2 minutes at room temperature. The tube
was centrifuged briefly to remove drops and 200 pl buffer AL was added to the sample.
The tube was again pulse-vortexed for 15 seconds and incubated for 10 minutes at 70°C.
200 pl of 96-100 % ethanol was added and mixed by pulse-vortexing for 15 seconds.
Once again the tube was briefly centrifuged to remove drops. Next, the mixture
(including precipitate) was carefully applied to the QIAarnp spin column in a collection
tube (2 ml) without wetting the rim. The cap was closed and the tube was centrifuged at
8000 rprn for 1 minute. The spin column was placed in a clean collection tube and the
tube containing the filtrate was discarded. The spin column was carefully opened and 500
pl of buffer AW 1 was added without wetting the rim. . The cap was closed and the tube
was centrifuged at 8000 rpm for 1 minute. The spin column was placed in a clean
collection tube and the tube containing the filtrate was discarded. 500 pl of buffer AW2
was then added to the spin column without wetting the rim and centrifuged at 14000 rprn
for 3 minutes. The spin column was placed in a new 2 ml collection tube and centrifuged
at 14000 rprn for 1 minute. Once again the spin column was placed in a clean collection

tube and 200 pl buffer AE was added to the tube which was then incubated at room
temperature for 5 minutes and centrifuged at 8000 rpm for 1 minute. The latter elution
step was repeated 3 times and finally the purified DNA was stored at in buffer AE at
-2O0C.

Transfer of pure DNA into XL1-Blue competent cells

Plasmid pHN1910, encoding an amino-terminal histidine-tagged version of the
hTdpl protein sequence, was transformed into competent cells. XL1-Blue competent
cells are usually the strain of choice for preparation of high-quality plasmid DNA. For
our transfer experiment, 30 pl cells were thawed on ice. 1 pl of DNA purified from noncompetent cells was directly pipetted into the competent cells and mixed by tapping
gently. The vial was incubated on ice for 5 minutes and then incubated for exactly 30
seconds in a 42°C water bath without mixing or shaking. The vial was removed from the
bath and placed on ice. To this mixture, 250 pl of pre-warmed SOC medium (2%
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgC12,10 rnM MgS04
and 20 mM glucose) was added. SOC is a rich medium and therefore sterile technique
was practiced to avoid contamination. The vial was placed in a microcentrifuge rack on
its side and secured with tape to avoid loss of the vial. The vial was then incubated at
37OC for exactly 1 hour in a shaking water bath set at 225 rpm. After incubation, 200 pl
of the mixture from the vial was spread onto an agar plate pre-treated with 25 mgml
ampicillin. In order to obtain well-spaced colonies, 1 pl of the mixture was diluted 1:100
with LB medium and then spread on another ampicillin pre-treated agar plate. The plates
were inverted and incubated at 37OC overnight. The next day a single colony was selected

and inoculated into 6 ml LB medium and grown overnight at 37 OC. The overnight
culture should turn turbid. 1 ml of this overnight culture was then added into I L LB
medium (1:1000 dilution), which was pre-treated with 25 mg/ml ampicillin, and grown
with vigorous shaking at 37 OC for at least 6 hours. Once turbidity starts to show, an
aliquot was removed and the optical density (OD) checked at 600 nm,using LB (with no
cells but antibiotic) as a blank. Once the required OD of 0.8- 1.0 has been reached, IPTG

(isopropyl-p-D-thiogalactopyranoside)was added to a final concentration of 1 rnM. IPTG
is a non-metabolisable artificial inducer of the lac operon. As a lac operon inducer, IPTG
has been successfully used to increase the production of recombinant proteins produced
in E. coli. The culture was allowed to shake vigorously at 37 OC for at least 2 hours. Cells
were then pelleted by centrifugation at 4000 x g for 20 minutes at 4 O C and resuspended
in buffer containing 20 mM sodium phosphate, pH 7.4. The cell suspension was then
sonicated in order to lyse the cells and this suspension was used for purification of
recombinant enzyme.

Recombinant hTdpl was purified using HiTrap Nickel Chelating columns.

HiTrap Chelating, when charged with ~

iions,
+ will
~ selectively bind proteins if complex-

forming amino acid residues, in particular histidine, are exposed on the surface of
proteins, e.g. poly-histidine tagged recombinant proteins. Proteins can be purified directly
from bacterial lysates and are recovered from the matrix under mild elution conditions,
using imidazole, which preserve antigenicity and functionality of the protein. The
properties of the matrix give the opportunity to perform a complete purification in just
10-15 minutes maintaining high selectivity and binding capacity. No special equipment is

required, just a syringe is enough to perform purification. A HiTrap Chelating HP 1 ml
column was used for our purification procedure. Prior to use, the column was pre-washed
with 5 ml of distilled water using a syringe. For charging with ion, the column was then
loaded with 0.5 ml of 0.1 M NiS04in distilled water. The column was then washed a
second time with 5 ml distilled water to remove any unbound metal ions. Once the
sonicated cell suspension containing the recombinant protein was loaded, the columns
was washed with 5 ml binding buffer containing 0.02 M sodium phosphate, 0.5 M NaCl
and 5 mM imidazole, pH 7.4. Recombinant enzyme was eluted using 5 ml of elution
buffer containing 0.02 M sodium phosphate, 0.5 M NaCl and 0.5 M imidazole, pH 7.4.
The eluted protein was stored at 4OC.

Cloning of Tdpl gene into pFLAGCMV2 human expression vector

pFLAG-CMV2 human expression vector consists of a FLAG epitope tag that
provides a method to localize gene products in living cells, identifl associated proteins,
track the movement of tagged proteins within a cell, and characterize new genes without
creating protein-specific antibodies. Previously, the full length coding sequence of human
Tdpl was PCR-amplified and cloned into the BamHI sites of the PET-15b expression
vector4', which adds a His-tag and a thrombin cleavage site to the N-terminus of Tdpl
and then transformed into E.coli. This PET-Tdpl plasmid was cut with BsffiI restriction
enzyme; the gap filled in and then again cut with BamHI restriction enzyme to release the
Tdpl gene. The gene was then cloned within the Bgl II and EcoRV sites of the pFLAGCMV2 vector and the ends ligated with the help of ligase at 16OC for 16 hours. A 0.8%
agarose gel was run to check for correct ligation.

Transient Transfection of FLAGTdpl and Untagged-Tdpl into 293B embryonic
kidney cells

Cells were seeded in 10 ml D-MEMJF-12media from Life Technologies in
150mm dishes until 80% confluence was reached on the day of transfection. Cells were
incubated under normal growth conditions (37°C and 5% C 0 2 ) .On the day of
transfection, a total of 25 pg DNA (FLAG-tagged Tdpl or Untagged-Tdpl) for 5 plates
(5 pg/ plate), dissolved in TE buffer, was diluted with cell growth medium (D-MEME12) containing no serum, proteins, or antibiotics to a total volume of 750 pl.The solution
was mixed and spun down for a few seconds to remove drops from the top of the tube.
150 fl of SuperFect Transfection Reagent, purchased from Qiagen, was added to the
DNA solution and mixed by pipetting up and down 5 times, or by vortexing for
1Oseconds. The samples were incubated for 5- 10 minutes at room temperature to allow
transfection-complex formation. While the complex formation was taking place, the
growth medium from the 150 rnm dishes was gently aspirated and the cells were washed
once with 10 ml PBS. 7.5ml of D-MEMfF-12 medium containing serum and antibiotics
was added to the reaction tube containing the transfection complexes, mixed by pipetting
up and down twice, and immediately transferred to the cells in the 150 rnm dishes. Cells
were incubated with the transfection complexes for 2-3 hours on a rotating platform
under their normal growth conditions. At the end of the incubation time, the medium
containing the remaining complexes was removed by gentle aspiration and fresh cell
growth medium containing serum and antibiotics was then added to the dishes and cells
incubated for 48-72 hours before purification of Tdpl .

Purification of recombinant Tdpl protein by Pull-down with Flag Beads and elution
with Flag Peptide (by detergent)

Extracts were prepared by first washing recombinant Tdpl transfected 293B cells
from five 150 mm plates, with ice-cold PBS extensively. 4 ml of lysis buffer (10 mM
Hepes, 60 mM KC1,l mM EDTA, 0.5% NP-40,0.5 mM PMSF, 0.5 mM DTT, 110 rnM
NaN04, 0.5 pgml leupeptin, 0.5 pgml pepstatin) was added and cells were lysed on ice
for 10 minutes. Lysed cells were spun at 2000 rpm for 5 minutes and the pellet containing
nuclei was saved. The supernatant was re-spun for 10 minutes at 14000 rpm. After
centrifugation, 4 ml TE (10 mM Tris-HC1,O.l mM EDTA; pH 8.0) containing protease
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) and 80-120 pl of Flag beads (washed
with PBS) were added to the supernatant and the reaction incubated at 4OC on a rotating
platform for 3 hours. The reaction was spun at 5000 rpm for 6 minutes. The beads were
subjected to different washes containing 1X TE alone or 1X TE and 0.15 M NaCl or 0.5
M NaCl or 1 M NaCl or 0.5 M LiCl or a combination of 1X TE, 0.15 M NaCl and 1%
Triton or 1X TX, 1 M NaCl and 1% Triton or 1X TX, 0.5 M LiCl and 1% Triton. Beads
washed twice with 1 ml 1X TE containing protease inhibitors followed by washing twice
with 1 ml TE containing PMSF only were subjected to western blot analyses to look for
the co-precipitation of either XRCCl or Ku with Tdpl. Beads subjected to washes with
different salt concentrations followed by washing twice with 1 ml 1X TE containing
PMSF were subjected to western blot analyses to look for presence of purified Tdpl
alone. After washing, 200 pl TE containing PMSF, 8 pl Flag peptide (Sigma, stock no.F3290, concentration-4mg) and 1 pl 100 pM DTT were added to the beads and

incubated on a shaker at 1200 rpm overnight at 4°C. The reaction was spun at 5000 rprn
for 6 minutes and 20% v/v of glycerol was added to the supernatant. Purified Flag-tagged
Tdpl was then stored at -20°C.

Purification of recombinant Tdpl protein by Pull-down with Flag Beads and elution
with Flag Peptide (by dounce homogenization)
Extracts were prepared by washing recombinant Tdpl transfected 293B cells from
five 150 rnrn plates, with ice-cold PBS three times and once in ice-cold hypotonic lysis
buffer containing 10 mM Tris-HC1; pH 8.0, 1 mM EDTA and 5 mM DTT. Cells were
resuspended in 2 volume of hypotonic lysis buffer for 20 minutes at O°C. Cells were then
lysed by dounce homogenization (- 20 strokes with a pestle). To the lysed cells, protease
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) were added and incubated for 20
minutes on ice, following which high salt buffer containing 50 m M Tris-HC1; pH 7.5, 1
M KC1,2 mM EDTA and 2 mM D m was added. The extract was centrifbged for 1 hour
at 15000 rpm and the supernatant was dialyzed over night against E buffer (20 mM TrisHC1; pH 8.0,O.l M KOAc, 20% voVvol glycerol, 0.5 rnM EDTA and 1 mM D m . The
next day, 4 ml TE (10 mM Tris-HC1,O. 1 mM EDTA; pH 8.0) containing protease
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) and 80-120 pl of Flag beads (washed
with PBS) were added to the supernatant and the reaction incubated at 4°C on a rotating
platform for 3 hours. The reaction was spun at 5000 rpm for 6 minutes. The beads were
washed twice with 1 ml TE containing protease inhibitors and twice with 1 ml TE
containing PMSF only. After washing, 200 pl TE containing PMSF, 8 pl Flag peptide
and 1 pllO0 pM DTT were added to the beads and incubated on a shaker at 1200 rpm

overnight at 4OC. The reaction was spun at 5000 rpm for 6 minutes and 20% vlv of
glycerol was added to the supernatant. Purified Flag-tagged Tdpl was then stored at 20°C.

Whole-cell extract preparation from lymphoblastoid cells obtained from SCAN1
patients (JRL1, JRL3, JRL4), from unaffected relatives (JRL2, JRLS) and from
known heterozygous carriers (JRL6, JRL7).
The various cell-lines were obtained from Dr. James Lupski, Baylor
University. Whole-cell extracts were prepared by growing cells in suspension culture
using RPMI 1640 medium containing 10% FCS until a cell density of 2.5 to 5.0 x 1o5
cellslml was reached. After extensive washing with PBS, the cells were incubated in 2
volume (pellet volume) hypotonic buffer (10mM Tris-HC1 (pH 7.0), IrnM EDTA, 5 m M

DTT) for 20 minutes at O°C to induce cell swelling. The cells were subjected to
mechanical shearing by the use of a Dounce homogenizer. Afier 10-20 strokes, protease
inhibitors (PMSF, leupeptin, pepstatin) were added and incubated for 20 minutes on ice.
0.5 volume high salt buffer (50mM Tris-HC1 (pH 7.5), 1M KCl, 2mM EDTA, 2mM

DTT) was added and centrifuged for 1 hour at 15000rpm.The supernatant was subjected
to overnight dialysis at 4OC with E-buffer (20mM Tris-HC1 (pH 8.0), 0.1M KOAc, 20%
V/Vglycerol, 0.5mM EDTA, ImM DTT). Following dialysis, the extract was aliquoted
and fast-fkozen using liquid nitrogen to be stored at -70°C.

Gel Filtration Chromatography and end-processing assays with GM00558B
fractions

Gel filtration was performed using a pre-packed 1.6 cm x 60 cm (190 ml bed
volume) Sephacryl S-300 column (Pharmacia). The column was set up in the cold room
and pre-washed with 2 column volumes (120 ml) of end-joining buffer (50 mM
triethanolamine HC1160 mM KOAcl 0.5 mM magnesium acetate1 2 rnM ATPI 1 mM
D m 1 100 pglml BSA). Glycerol was omitted fiom the end-joining buffer in order to
reduce column flow pressure and facilitate column flow. The column was connected to a
peristaltic pump whose rate was set such that 1 ml fractions were collected every seven
minutes. Degassed and filtered buffer was pumped through the column. Prior to loading
the extract, a standard curve was obtained using molecular weight markers (Bio-Rad)
ranging fiom 1.7 kDa to 650,000 kDa. Five peaks corresponding to five different colorcoded markers were recorded. Next, the column was again washed with 1 column volume
of end-joining buffer before loading the extract. 1 ml of undiluted human lymphoblastoid
cell extract (10 mglml) was thawed at 37OC for 5 minutes followed by
microcentrifugationat 10,000 rpm for 5 minutes to remove any debris in the extract.
Debris-free extract was then loaded onto the column and elution buffer containing 20

mM Tris-HC1, pH 7.51 0.1 M KOAcI 0.5 mM EDTAI 1 mM D m , 2 mM ATPI and 100
pglml BSA was applied with a peristaltic pump at 0.14 mllmin.

was recorded and 2

ml fractions were collected overnight and stored at 4OC.
End-processing assays with the fractions (10 pl) showing peak-enzyme activities
were performed using 6 pl of each fraction in buffer containing 20 mM triethanolamineHC1, pH 7.51 60 mM KOAcI 0.5 mM magnesium acetate1 2 mM ATPI 1 mM D?T/ 100
pglml BSA and 20% (vlv) glycerol. The reaction buffer contained 0.5 rnM EDTA, and
therefore the magnesium acetate concentration in the reactions was adjusted so that the

final fi-ee M ~concentration
+ ~
would be 0.5 mM. In some experiments M ~was
+ ~
completely eliminated and instead, various concentrations of EDTA were used. 20 fino1
of 3'-PG ss-14 mer or 3'-phosphotyrosine ss-18 were used for the reactions. Following
incubation at 37OC for 2 hours, the oligomeric substrate was diluted with one volume of
formamide containing 40 mM EDTA and electrophoresed on 20% denaturing
polyacrylarnide-sequencinggels. Phosphorimages were analyzed with ImageQuant 3.3
(molecular dynamics).

End-processing assays of a double-stranded substrate with a 3'-PG overhang by Ku,
DNA-PK and XRCC4-ligase IV.
A double-stranded substrate with a 3'-PG overhang was pre-incubated with
various dilutions of recombinant Ku or Ku-DNA-PK complex for 5 minutes at 25 OC to
allow binding to the open end of the substrate followed by incubation with a 1:512
dilution (0.098 ng) of hTdpl (diluted using Pouliot dilution buffer containing 50 mM
Tris-HC1, pH 8.01 5 mM D W 100 mM NaCll 5 mM EDTN 10% glycerol1 500 pdml
BSA) for 10 minutes at 37 "C to allow PG-processing. If XRCC4-ligase IV was to be
added, it was added after pre-incubation with the Ku-DNA-PK complex and before
addition of Tdpl (and pre-incubated for 5 minutes at 25°C). End-processing assays of the
double-stranded substrate with a 3'-PG overhang by Ku were carried out in Kedar buffer
containing 20 mM triethanolamine-HCl, pH 7.51 60 mM KOAcl 0.5 mM magnesium
acetate1 2 mM ATPI 1 mM DTTI 100 pglml BSA and 20% (vlv) glycerol. 3 M sodium
acetate and 1 mdml tRNA were added to final concentrations and samples were then
subjected to phenollchloroform extraction. After extraction of Ku, samples were

dissolved in 1X TE. NEB buffer 4 and 40 W m l PNKP were added and samples

+ not
~ added separately as it was already present in
incubated for 1 hour at 37 "C. M ~was
the reaction buffer. AvaI was added and samples were incubated for 3 hours at 37 "C to
yield a 15-mer with the 3'-OH. The samples were then electrophoresed on 20%
denaturing polyacrylamide-sequencing gels. Phosphorimages were analyzed with
IrnageQuant 3.3 (molecular dynamics).

. End-processing assays consisting of DNA-PK alone, Ku-DNA-PK complex and
Ku-DNA-PK-XRCC4fligaseIV
complex were carried out in Ramsden buffer containing
25 mM Tris-HC1, pH 7-5150 pglml BSN 45 mM KC11 105 mM NaCV 0.05% Triton X10010.1 mM EDTN 2 mM DTT.If the Ramsden buffer was used, 0.2~1
of a mixture of
100pM ATP and 5 mM MgC12was added as required along with the hTdpl . For
experiments conducted without ATP, MgC12was also not added. Following boiling of the
samples at 90°C for 2 minutes, the substrate was incubated with 1 pl of 1000 units1 mL
alkaline phosphatase (CP) for 1 hour at 37OC for removal of 3'-terminal phosphate
group. The samples were again heated at 90°C for 5 minutes and then incubated with 1 pl

TaqaI (20,000 unitslml) for 3 hours at 65°C to yield a 15-mer with the 3'-OH. The
samples were then electrophoresed on 20% denaturing polyacrylamide-sequencinggels.
Phosphorimages were analyzed with ImageQuant 3.3 (molecular dynamics).

Western Blotting

10% SDS-polyacrylamidegels were used for western blotting. A large and a
small glass plate were cleaned with 70% ethanol and dried with kim-wipes and aligned in
a gel caster. Resolving gel (20ml) was prepared with 8.8 mL milliQ water1 4.2 mL1.5 M

Tris-HC1, pH 8.81 6.6 mL 30% acrylamidel166 pL 10% SDSJ 166 pL 10% ammonium
persulfate and 67 pL TEMED. Stacking gel (3 mL) was prepared with 2.1 mL milliQ
water/ 0.5 mL 30% acrylamide/ 0.38 mL 1 M Tris-HC1, pH 6.81 30 pL 10% SDS/ 30 pL
10% ammonium persulfate and 3 pL TEMED. 10 pl aliquots of whole-cell extracts or
purified Tdpl were mixed with 2 p15X sample buffer containing 1 M Tris, pH 6.81 5 %
glycerol/ 10% SDSI 5 % P-mercaptoethanoV 2% bromophenyl blue, denatured by boiling
for 5 minutes and electrophoresed on the 10% SDS-polyacrylamidegel in running buffer
containing 25 mM Tris base/ 250 mM glycine and 0.1 % SDS. Electrophoresis was
carried out at 100V for the first 8 minutes followed by 200V for the next 40 minutes. The
gel was removed and the stacking gel cut off. The resolving gel was then put into transfer
buffer containing 25 mM tris base1 192 mM glycine and 20% methanol. The 'transfer
sandwich' was assembled fiom the black side of the cassette to the white side with
sponge, Whatman filter paper, the gel followed by nitrocellulose membrane followed
again by Whatman filter paper and finally by another sponge. The sandwich was put into
the transfer box, black side to back. A spacer pack frozen at -20°C was also put into the
transfer box. Transfer buffer was poured in and the transfer was carried out at 100V for
-2 hours. Following transfer, the nitrocellulose membrane was stained with Ponceau S
stain to check for completion of transfer. The dye was rinsed off with distilled water and
the membrane was transferred into blotto solution made up of 10 rnM Tris, pH 7.4, NaCl
and 5% non-fat dry milk. The membrane was blocked in blotto overnight at 4OC with
continuous rocking. Next day, the respective primary antibodies were mixed in fresh
blotto (Table 1). Incubation with primary antibody was carried out at room temperature
for -2 hours with continuous rocking. The primary antibodies were washed off twice

using 20 mL Blotto wash containing 0.05% Nonidet P-40 and 1X PBS. Each wash was
carried out for 15 minutes. The membrane was then incubated with the required
secondary antibody for 1 hour at room temperature. The blot was then subjected to two
washes, each for 15 minutes, with 20 mL Tris-Buffered Saline (TBS)-Tween 20. For
cherni-luminescence, 500 pl of each of the two super signal solutions (Pierce, Rockford,

IL)were mixed and the blot was exposed to the solution for about 1 minute followed by
autoradiography.
TABLE 1.
PRIMARY
ANTIBODY

Rabbit antihTdp 1
(Abcarn Inc.;
Cat No.ab4 166)
Mouse AntiFLAG
(Sigma; Cat
NO.-F-3 165)
Rabbit antiKu 70
(Serotec Inc.;
Cat No.AHP3 16)

VOLUMES
FOR
INCUBATION

-

SECONDARY
ANTIBODY

DILUTION
USED

1:1000

10 pl in 10
rnL

Goat antirabbit

1:10,000

1:2000

5Nin10

Goat antirabbit

l:lO,OOO

DILUTION

USED

1:2000

-

INCUBATION

1i

n 10

10 pl in 10
(NeoMarkers;
Cat No.- MS434-PI)
Rabbit antiXRcc4
(GeneTex,
Inc.; Cat No.-

mL
1:1000

10 pl in 10

: Goat anti-

1:10,000

1 pl in 10

rabbit

mL

1
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Results

Tyrosyl-DNA phosphodiesterase (Tdp1) is capable of removing glycolate from 3′-PG
overhangs.
Tdp1 is the only enzyme known so far to convert any 3′-blocked termini to 3′phosphates. The first report of an activity that cleaves a 3′-tyrosyl-phosphodiester bond
was reported in 1996. Using column chromatography, Yang et al partially purified this
activity from crude extracts of budding yeast S. cerevisiae as a ~55 kDa enzyme
independent of any cofactor requirement to function. The enzyme specifically cleaved the
phosphodiester bond that connected the 3′-end of DNA to a tyrosine in the active site of
topoisomerase I enzyme, thus liberating a 3′-phosphate ended DNA molecule (Yang et
al., 1996). Such linkages are formed as intermediates during DNA relaxation by
topoisomerase I, and in DNA cleavage and reunion by various recombinases. These
intermediates can become trapped if the process is interrupted, e.g., by a topisomerase
inhibitor or by collision with a replication fork. The hypersensitivity of tdp1 mutant yeast
to topoisomerase I-mediated DNA damage (Pouliot et al., 1999) suggests a critical role
for scTdp1 in repair of such lesions. Later, a gene (TDP1) encoding this enzyme was
identified in yeast, which was conserved in eukaryotes. Analysis of single and double
mutants of TDP1 and RAD52 suggests that both belong to the same epistasis group while
TDP1 and RAD9 belong to different groups (Pouliot et al., 2001). A human homologue
with similar 3′-phosphotyrosyl- processing activity, hTdp1, was cloned by homology to
scTdp1 and was eventually shown to have some homology to the phospholipase D (PLD)
superfamily of phosphodisterases (Interthal et al., 2001). Yeast and human Tdp1 differ
from other activities for processing blocked 3′ ends in that they leave a 3′-phosphate
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Figure 1: 3'-PG (·) and 3'-phosphotyrosine (p-Tyr) substrates.
The 3'-PG oligomers were prepared by bleomycin treatment of partial duplexes.
* indicate the site of the 32P label. The plasmid substrate is 5.5kb in length.
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Figure 2: Conversion of 3'-phosphotyrosine termini to 3'-phosphate termini by
native hTdp1.
20fmol of 3'-phosphotyrosine 18-mer was treated with 6µl Sephacryl fractions 20-40
from human whole-cell extracts in Kedar buffer containing 20 mM triethanolamine-HCl,
pH 7.5/ 60 mM KOAc/ 5 mM EDTA/ 2 mM ATP/ 1 mM DTT/ 100 µg/ml BSA and 20%
(v/v) glycerol. Samples were incubated for 2 hours at 37°C and conversion to 3'phosphate was assessed by denaturing gel electrophoresis. Fractions 27-30 showed 100%
conversion to 3'-phosphate.
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rather than a 3′-hydroxyl. To determine whether the activity for removal of glycolate
from single-stranded 3′-PG termini in human cell extracts might be hTdp1, we
fractionated extracts by gel filteration chromatography on Sephacryl S-300 (Inamdar et
al., 2002). A prominent peak of glycolate-removing activity was found to colelute with
hTdp1 protein as detected with hTdp1 antiserum at a position approximately midway
between the 44- and 158-kDa markers. In the presence of EDTA, this fraction was found
to catalyze the 3′-PG-to-3′-phosphate conversion with no detectable formation of 3′hydroxyl (Figure 3).
No evidence of multiple forms of the enzyme separable by the sephacryl column
Previously in our laboratory, titration of the activity in the peak fraction showed
that it processed a 3′-phosphotyrosine oligomer 8-fold more efficiently than a plasmid
containing PG-terminated 3′-overhang (Figure 4), consistent with its identification as
hTdp1 (Inamdar et al., 2002). However, the peak of PG-processing activity seemed to be
slightly shifted from the peak of hTdp1 as detected with an antibody, raising the
possibility of multiple forms with differing PG-processing efficiencies. To determine
whether this difference in processing efficiencies was due to the presence of different
splice forms of hTdp1, we duplicated the above experiment and four fractions showing
peak activity were chosen. The plasmid containing the 3′-PG terminated single-strand
overhang was replaced by a 3′-PG containing 14-mer. Titration experiments using each
of the 4 fractions showed that hTdp1 processed the 3′-phosphotyrosine containing 18-mer
10-fold more efficiently than the 3′-PG containing 14-mer (Figure 5). Since the Sephacryl
S-300 column separates different fractions based on size, we conclude that there was no
evidence of splice variants or other multiple forms of the enzyme.
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Figure 3: Conversion of 3'-PG termini to 3'-phosphate termini by native hTdp1.
20 fmol of 3'-PG 14-mer was treated with 6µl Sephacryl fractions 24-35 in Kedar buffer
containing 20 mM triethanolamine-HCl, pH 7.5/ 60 mM KOAc/ 5 mM EDTA/ 2 mM
ATP/ 1 mM DTT/ 100 µg/ml BSA and 20% (v/v) glycerol. Samples (a total volume of 10
µl) were incubated for 2 hours at 37°C and conversion to 3'-phosphate was assessed by
denaturing gel electrophoresis.
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Figure 4: Relative efficiency of native end-processing activities
A 3'-phosphotyrosine 18-mer (▲) or a plasmid with a PG-terminated 3'-overhang (●)
was treated with 4 µl of undiluted, followed by 1 µl of seven 1:4 dilutions of sephacryl
fraction 30 from human whole-cell extracts. Each substrate was incubated at 37 ºC for 2
hours in Kedar buffer containing 5 mM EDTA and no Mg2+ (see Fig. 2). Conversion to
3'-phosphate was assessed by denaturing gel electrophoresis and quantified using
ImageQuant software. The difference in relative end-processing efficiency was found to
be approximately 8-fold.
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Figure 5: Relative efficiencies of native end-processing activities.
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 4 µl of
undiluted, followed by 1 µl of seven 1:4 dilutions of sephacryl fractions 27-30. Each
substrate was incubated at 37 ºC for 2 hours in Kedar buffer containing 5 mM EDTA and
no Mg2+. Conversion to 3'-phosphate was assessed by denaturing gel electrophoresis and
quantified using ImageQuant software. The difference in end-processing efficiencies
between the two substrates was found to be approximately 10-fold in each of the four
fractions.
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Processing efficiency of scTdp1 is affected by various factors
Previously, experiments using scTdp1 showed that, compared with its hydrolysis
of a 3′-phosphotyrosine residue, scTdp1 or yTdp1 removed 3′-PG very inefficiently
(Pouliot et al., 2002). When a mixture containing roughly equimolar amounts of an 18mer containing 3′-phosphotyrosine and a 21-mer containing 3′-PG was incubated with
scTdp1 at 30°C for 20 minutes in buffer without EDTA, the 21-mer terminating in 3′-PG
required at least a 50-fold higher concentration of the enzyme to achieve a comparable
initial rate and at least a 100-fold increase in concentration to achieve a 50% conversion
rate. Based on these results, our laboratory decided to compare the processing efficiencies
of an 18-mer containing 3′-terminal phosphotyrosine with a 14-mer containing a terminal
3′-PG and a 19-mer containing a 3′-PG. In comparison to the experimental conditions
used by Pouliot et al., we incubated the substrates with the recombinant scTdp1 for 2
hours at 37°C in buffer containing EDTA (as was carried out by our laboratory with
hTdp1). The results showed that under these conditions, the difference between the
processing efficiencies of the 18-mer with 3′-phosphotyrosine and the 3′-PG containing
substrates was lesser (~ 10-fold) and both the 14-mer and the 19-mer containing terminal
3′-PG achieved 50% conversion of the substrate with approximately the same
concentration of the enzyme suggesting that the size of the substrate did not affect the
processing efficiency of recombinant yeast Tdp1 (Figure 6a). We next conducted two sets
of experiments in which one set containing a mixture of the 18-mer with
phosphotyrosine, 14-mer with 3′-PG and the 19-mer with 3′-PG was incubated with
scTdp1 for 20 minutes at 30°C, heated for 1 minute at 90°C, treated with 20 ng hPNKP,
again incubated for 1 hour at 37°C and electrophoresed on a denaturing polyacrylamide
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gel. hPNKP, a Mg+2 dependent enzyme, was added for conversion of 3′-phosphate to 3′P

P

OH which separates much better from 3′-PG on sequencing gels . The second set
consisted of a mixture of another 19-mer with terminal 3′-PG and scTdp1 supplemented
with 20 ng hPNKP that was incubated for 20 minutes at 30°C, heated for 1 minute at
90°C and then electrophoresed on a denaturing polyacrylamide gel. Both the sets of
reactions were carried out in buffer containing a final concentration of 0.5 mM MgCl2
B

and without EDTA. Our results showed that under these different conditions, the 18-mer
B

with terminal 3′-phosphotyrosine was processed ~20-fold more efficiently than the 14mer containing terminal 3′-PG (when compared to the ~ 10-fold difference in our
previous experiment). Also, there was at least an 8-fold difference in the processing
efficiencies between the 14-mer and 19-mer 3′-PG substrates making the processing
difference between the 3′-tyrosine substrate and 3′-PG containing 19-mer ~100-fold
(Figure 6b). All these data suggested that the relative efficiency of the yeast enzyme was
affected by different experimental conditions such as temperature and time of incubation.
It was shown previously that both human and yeast recombinant enzymes converted 3′PG termini to 3′-phosphate termini in either the presence or absence of Mg+2 (Inamdar et
P

P

al., 2002). However, omitting EDTA from the buffer and adding Mg+2 in our experiments
P

P

was also found to affect the activity of scTdp1. The combination of buffer, temperature
and oligo length effects can explain the apparent disparity between our results (Inamdar
et al., 2002) and results from Pouliot et al. (2002).
Recombinant human Tdp1 shows relatively lower 3′-PG removal activity than
partially purified native hTdp1
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Figure 6: Relative end-processing efficiencies of recombinant scTdp1.
6a- 28, 7, 1.75, 0.44, 0.11, 0.027, 0.0068 or 0.0017 ng of recombinant yeast Tdp1 was
incubated with 3’-phosphotyrosine 18-mer (■) or a 3’-PG 14-mer (▲) or a 3’-PG 19-mer
(♦) in end-joining Kedar buffer containing EDTA for 2 hours at 37 °C. Conversion to 3’phosphate was analyzed by PAGE and results were quantified using ImageQuant
software.
6b- 28, 7, 1.75, 0.44, 0.11, 0.027, 0.0068 or 0.0017 ng of recombinant yeast Tdp1 was
treated with 3’-phosphotyrosine 18-mer (○) or a 3’-PG 14-mer (●) or a 3’-PG 19-mer
(▲), incubated at 30 °C for 20 mins in Kedar buffer and heated at 90°C for 1 min. 20 ng
of human PNKP was added and samples were incubated at 37°C for 1 hour and analyzed
by gel electrophoresis. A second 19-mer with 3’-PG (∆) was treated with both yeast Tdp1
and hPNKP together and incubated at 30 °C for 20 mins before being analyzed. EDTA
was not present; instead a final concentration of 0.5 mM MgCl2 was added to the buffer.
B

B

58

Conversion (%)

100
80

18 Y

60
40

14-PG

20

19-PG

0
0.001

0.01

0.1

1

10

100

scTdp1 (ng)

Figure 6a

scTdp1 reactions with 18y, 14pg and 19pg
100

% Conversion

19P

18 Y

80

60

14-PG

40

20

19PG
0
0.001

0.01

0.1

1

Log Dilution
scTdp1
(ng)

Figure 6b

10

100

59

Previously, experiments conducted to determine the efficiency of the processing
of 3′-PG termini by hTdp1 using a 3′-phosphotyrosine DNA oligomer and a DSB
substrate with a PG-terminated 3′-overhang treated with various concentrations of the
recombinant His-tagged hTdp1, grown in E.coli, showed that the 3′-PG substrate required
an ~80-fold greater concentration of recombinant hTdp1 for half-maximal conversion
than did the 3′-phosphotyrosine oligomer, more than would have been expected based on
the activities in fractionated extracts (Inamdar et al., 2002). This difference in relative
preference for 3′ phosphotyrosine over 3′-PG substrates, 80-fold for purified recombinant
hTdp1 versus 10-fold for native activity in extracts, raised the question of whether most
of the native PG-processing activity might be attributable to some functionally similar but
distinct enzyme. While this possibility has not been completely eliminated, it seems
unlikely, as such an enzyme would have to precisely co-elute with hTdp1 from the
Sephacryl S-300 column and would also have to cross-react with antibody against the
recombinant hTdp1 to explain immunodepletion data observed previously (Inamdar et al.,
2002). To determine whether this difference in processing efficiencies was due to
degradation of the enzyme (provided by Dr. Jeff Pouliot, NIMH) during its shipping
and/or its freezing and thawing, we purified recombinant hTdp1 in our laboratory using
Amersham Hi-Trap nickel chelating columns and repeated the experiment. Our results
still showed a 100-fold difference in the processing activities (Figure 7) suggesting that
the different substrate preferences may likely be attributable to other factors such as the
presence of the histidine tag, interactions with other proteins in the fractionated extract
that may enhance activity or differences in post-translational modification in human
versus bacterial cells.
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Figure 7: Relative end-processing efficiency of recombinant hTdp1
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 4 µl of
undiluted, followed by 1 µl of six 1:4 dilutions of recombinant His-tagged hTdp1,
purified from E.coli. Each substrate was incubated at 37 ºC for 2 hours in Kedar buffer
containing 5 mM EDTA and no Mg2+. Conversion to 3'-phosphate was assessed by
denaturing gel electrophoresis and quantified using ImageQuant software. The relative
end-processing efficiency was found to be approximately 100-fold.
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No evidence of the Flag peptide having any effect on the specificity of the enzyme
To assure that hTdp1 has normal post-translational modification and also to avoid
any inactivation due to exposure of the enzyme to the nickel column (as was seen with
PNKP; M.Weinfeld, personal communication), our laboratory cloned the Tdp1 gene into
the human expression vector, pFLAG-CMV2 (Figure 9). The pFLAG-CMV2 vector
consists of a FLAG epitope tag that provides a method to localize gene products in living
cells, identify associated proteins, track the movement of tagged proteins within a cell
and characterize new genes without creating protein-specific antibodies. Untagged Tdp1
was cloned into pCMV-M human expression vector and used as a negative control for
our experiment. The pFLAG-CMV2 vector containing the cloned Tdp1 gene was
transfected into 293B embryonic kidney cells, and overexpressed hTdp1 protein was
purified using FLAG beads and eluted with FLAG peptide (Figures 11a and b).
Untagged-Tdp1 was also cloned into pCMV-Tag1 human expression vector (Figure 10),
transfected, purified and used as a negative control for our experiment. We carried out a
western blot analysis that showed a high and approximately equal expression of Tdp1 in
whole cell extracts from cells with both FLAG-tagged Tdp1 and Untagged-Tdp1. We
also observed recovery of FLAG-tagged hTdp1 and no recovery of Untagged-hTdp1 after
purification with FLAG beads suggesting that only the tagged protein was bound to and
eluted from the beads as expected (Figure 11c). When the processing efficiencies of
whole cell extracts containing either FLAG-tagged Tdp1 or Untagged-Tdp1 were
compared, we observed about the same 100-fold difference in processing efficiencies for
3'-PG and 3'-phosphotyrosine oligomers as with recombinant hTdp1 purified from Hi-
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Figure 8: The pET-15b E.coli vector; the source for His-tagged Tdp1 gene.
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Figure 8
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Figure 9a: The pFLAG-CMV2 human expression vector used for cloning Tdp1 gene.
Figure 9b: Protocol for cloning.
Tdp1 insert was excised from pET 15-Tdp1 as a Bam HI-BsrGI fragment, filled in with
BsrGI and cloned into the BglII and EcoRV sites of the vector to give rise to a plasmid
encoding FLAG-tagged Tdp1, designated as pCMV-FLAG-Tdp1.
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Figure 9a
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Figure 9b
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Figure 10: The pCMV-Tag1 human expression vector used for cloning Tdp1 gene.
Flag and c-myc epitopes were removed. Within the Tdp1 insert a pyrimidine at –3
position to an ATG sequence was replaced with a purine to ensure normal translation.
The product formed was untagged Tdp1 which was used as a negative control.
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Figure 10
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Protein gel using silver staining
A protein gel was carried out to estimate the concentration of FLAG-hTdp1 purified by
dounce homogenization and by using detergent from both pFLAG-Tdp1 transfected 293B
human embryonic kidney cells and from adenovirus infected U-87 glioma cells. 30, 100,
300, 1000 or 3000 ng of BSA was loaded onto separate wells as controls.
11a: The last 4 wells contain 2 µl of FLAG-hTdp1 purified using detergent from U-87
cells, 5 µl and 2 µl of FLAG-hTdp1 purified using dounce homogenization from 293B
cells and 2 µl of FLAG-hTdp1 purified using detergent from 293B cells respectively.
11b: The last 4 wells contain 2 µl of FLAG-hTdp1 from 293B cells, 4 µl of microdialyzed hTdp1, 4 µl each of 1st and 2nd hTdp1 elutions from U-87 cells. Each of these
samples was purified using 0.5% NP-40.
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Figure 11c: Western Blot analysis of whole-cell and purified extracts
A western (using Mouse anti-FLAG antibody) was carried out with samples containing
0.2 µl and 1µl whole-cell extracts containing FLAG-tagged hTdp1, 0.2 µl whole-cell
extract containing untagged hTdp1, 0.5 µl purified FLAG-hTdp1 and 0.5 µl untagged
hTdp1. Equal concentration of hTdp1 was found in the whole-cell extracts containing
FLAG-hTdp1 and untagged hTdp1. The sample containing purified FLAG-hTdp1
showed a band while the sample containing purified untagged hTdp1 did not show a band
proving that only FLAG-hTdp1 was purified using FLAG beads and FLAG peptide.
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Trap nickel chelating columns, suggesting that the FLAG tag has no effect on the potency
or specificity of the enzyme (Figure 12).
Better recovery of Tdp1 activity by NP-40 detergent lysis than by dounce
homogenization
In our laboratory, pFLAG-Tdp1, along with Superfect transfection reagent, was
transfected into 293B embryonic kidney cells. Following incubation for 3 days, the cells,
instead of being dounced as per usual experimental procedure, were treated with lysis
buffer containing Nonidet P-40 or NP-40 (a phenol-containing detergent) to lyse the cells
and release their cytoplasmic contents. Protease inhibitors were added and FLAG-Tdp1
was adsorbed onto FLAG beads and eluted with FLAG peptide. A protein gel using silver
staining was carried out to compare the protein content in the extracts purified using
dounce homogenization vs. extracts purified using 0.5% NP-40 (Figures 11a and b).
When we compared the processing efficiencies of FLAG-Tdp1 obtained using detergent
with that of FLAG-Tdp1 obtained via dounce homogenization, we observed that while
the former retained the 100-fold difference between phosphotyrosyl and PG-substrates as
seen with recombinant Tdp1 purified using Hi-Trap Nickel chelating columns, the latter
hardly showed any PG-processing even at undiluted concentrations. These results lead us
to use NP-40 for cell lysis rather than dounce homogenization while purifying FLAGTdp1 (Figure 13).
Relative processing efficiency of FLAG-hTdp1 cloned into an adenovirus was ~100fold
The many differences between bacterial and human cells lead us to clone human
FLAG-Tdp1 into an adenovirus and purify it from transduced human cells using FLAG
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Figure 12: Relative end-processing efficiencies of FLAG-hTdp1 and Untagged
hTdp1
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 1 µl of undiluted
or 1 µl of six 1:8 dilutions of extracts containing overexpressed FLAG-hTdp1 and
Untagged hTdp1. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. 20 mM Mg2+ and 20
ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel
electrophoresis and quantified using ImageQuant software. The difference in relative
end-processing efficiencies was found to be approximately 100-fold.
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Figure 13: To compare the end-processing efficiencies of FLAG-hTdp1 purified via
dounce homogenization vs. FLAG-hTdp1 purified using 0.5% NP-40
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 25, 3.125, 0.39,
0.048, 0.0061, 0.00077, 0.000095 or 0.0000012 ng of FLAG-hTdp1 purified using
dounce homogenization OR 50, 6.25, 0.78, 0.098, 0.012, 0.0015 or 0.0002 ng of FLAGhTdp1, purified using 0.5% NP-40. Each 5µl reaction was incubated at 37 ºC for 2 hours
in Kedar buffer containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. A
final concentration of 20 mM Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH
was assessed by denaturing gel electrophoresis and quantified using ImageQuant
software. Our results showed that the latter retained the 100-fold difference as seen with
recombinant Tdp1 purified using Hi-Trap Nickel chelating columns, while the former
hardly showed any PG-processing even at undiluted concentrations.
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beads and FLAG peptide. Once cloned, when the relative processing efficiency of FLAGtagged Tdp1 from purified adenovirus infected U87 glioma cells was compared, we
observed about the same 100-fold difference in processing efficiencies for 3'-PG and 3'phosphotyrosine oligomers (Figures 14a and 14b) as with recombinant hTdp1 purified
from bacteria using Hi-Trap nickel chelating columns, suggesting that if Tdp1 was posttranslationally modified in mammalian cells, these modifications did not have any effect
on the specificity of the enzyme.
Extracts of SCAN1 cells with mutant Tdp1 are deficient in PG-processing
A possible theory regarding patients suffering from spinocellebelar ataxia with
axonal neuropathy is that oxidative stress coupled with hTdp1 deficiency results in
persistent 3'-phosphoglycolates resulting in persistent DSBs and neuronal apoptosis. To
examine the molecular basis of SCAN1, blood samples were collected from 7 related
individuals of an affected Saudi Arabian family and Epstein-Barr virus transformed
lymphoblastoid cell lines were established by Dr. James Lupski. Upon receiving these 7
cell lines, named JRL1-7 respectively, we prepared whole-cell extracts and tested
dilutions of each extract for the processing of a 3'-phosphotyrosine containing 18-mer.
We observed that while JRL-1 and JRL-3 extracts showed no conversion of 3'phosphotyrosine to 3'-phosphate, undiluted JRL -5, 6 and 7 extracts catalyzed complete
conversion (Figure 15a). JRL-4 extract showed an extremely low conversion when
undiluted and no conversion with subsequent dilutions. These results suggested that JRL1 and 3 extracts contained mutated hTdp1 while JRL-5, 6 and 7 extracts contained the
wild-type hTdp1 and this was found to be in agreement with genetic and sequencing data;
JRL-1,-3 and –4 are homozygous Tdp1 mutants, JRL-2 and –5 are normal while JRL-6
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Figure 14a and 14b: Relative end-processing efficiency of FLAG-hTdp1 cloned into
an adenovirus.
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 50, 6.25, 0.78,
0.098, 0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from adenovirus infected U87 glioma cells. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final
concentration of 20 mM Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was
assessed by denaturing gel electrophoresis and quantified using ImageQuant software.
The difference in relative end-processing efficiencies was found to be approximately
100-fold.
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and –7 are heterozygous carriers. To assess whether this mutation resulted in deficiency
in 3'-PG processing, a 3'-PG containing14-mer was incubated with JRL-1, 5 and 6
extracts (Figure 15b). In JRL-1 whole-cell extract, PG processing was undetectable while
partial conversion to 3'-phosphate was seen in JRL-5 and JRL-6. This suggests that most,
if not all 3'-PG processing activity in extracts is attributable to Tdp1.
When the processing efficiencies of purified FLAG-tagged hTdp1 were compared
in our previous experiments, we observed that the 3'-phosphotyrosyl-containing 18-mer
was 100-fold more efficiently processed than the 3'-PG containing 14-mer. However,
addition of whole-cell extracts from Tdp1-mutant, JRL-1, to purified FLAG-hTdp1
reduced the ratio of phosphotyrosyl to PG processing activities from 100:1 to 10:1. Our
results showed that the 3'-phosphotyrosine processing efficiency decreased while the 3'PG processing efficiency increased on addition of JRL-1 extract (Figure 15c). These
results suggest that Tdp1 specificity is modulated by other factors in the whole-cell
extract.
No evidence for the presence of other Mg+2 –dependent PG-processing enzymes
Since whole-cell extracts of Tdp1-mutant SCAN1 cells showed no detectable
processing of 3'-PG-terminated oligomers, it was suggested that most, if not all, 3'-PGprocessing is attributable to Tdp1. However, these assays were conducted in the presence
of 5mM EDTA in the reaction buffer in order to inhibit nucleases that would otherwise
interfere with the detection of PG-processing activity of Tdp1. Mg+2 acts as a co-factor
for most nucleases. In the presence of this EDTA, any Mg+2 added would form a chelate
complex rendering it inaccessible to enzymes and therefore, Mg+2 –dependent PGprocessing enzymes, if present, would have been difficult to detect. In order to look for
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Figure 15: Relative end-processing efficiencies of SCAN1 whole-cell extracts (JRL 17)
15a: An 18-mer containing 3’-phosphotyrosine was treated with 1 µl of undiluted,
followed by 1 µl of two 1:8 dilutions of each of the seven JRL whole-cell extracts for 2
hours at 37° C in Kedar buffer with EDTA and samples were analyzed by polyacrylamide
gel electrophoresis. JRL 2, 5, 6 and 7 showed presence of wild-type hTdp1 while JRL 1,
3 and 4 seemed to contain no 3’-phosphotyrosine processing activity, consistent with
these cells harboring mutant hTdp1. JRL 4 also showed some residual activity.
15b: An 14-mer containing 3’-PG was treated with 1 µl of undiluted, followed by 1 µl of
four 1:8 dilutions of JRL whole-cell extracts-1, 5, and 6- for 2 hours at 37° C in Kedar
buffer with EDTA and samples were analyzed by PAGE. JRL 5 and JRL 6 showed a
partial conversion to 3’-phosphate at undiluted concentration.
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Figure 15c. Effect of addition of JRL 1 whole-cell extract to purified FLAG-tagged
hTdp1
An 18-mer containing 3’-phosphotyrosine or a 14-mer containing 3’-PG was treated with
50, 6.25, 0.78, 0.098, 0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from
adenovirus infected U-87 glioma cells. To another similar set, 1.8 µl of a 7mg/ml JRL 1
whole-cell extract (containing mutated hTdp1) was added along with the FLAG-hTdp1
and the substrate. Each set was incubated for 2 hours at 37° C in Kedar buffer with
EDTA and no ATP. Samples were then analyzed by polyacrylamide gel electrophoresis.
Our results showed that addition of JRL-1 whole-cell extract reduced the ratio of
phosphotyrosyl to PG processing activities from 100:1 to 10:1 (also refer to Fig 14b). The
3’-phosphotyrosine processing efficiency decreased while the 3’-PG processing
efficiency increased suggesting that Tdp1 specificity is modulated by other factors in the
whole-cell extract.
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the presence of such enzymes, a phosphorothioate- substituted 3'-PG substrate that is
nuclease-resistant was prepared in our laboratory. This thiolated oligo prevents 3'-> 5'
exonucleases from degradaing the DNA end. The oligomer was incubated with different
dilutions of JRL1 cells containing mutated Tdp1 in the presence of 100 mM Mg+2 and
subsequently treated with PNKP. We did not observe any conversion of the 3'phosphotyrosyl and 3'-PG substrates to 3'-OH, although at the highest concentration there
was some loss of both substrates, probably due to degradation by nucleases present in
extracts (Figure 16).
Processing of the single-strand PG terminated oligomer by human FLAG-Tdp1 is
independent of cofactor requirement
Cheng et al. in 2002 proposed that Mn2+ has a stimulatory effect on Tdp1 activity.
Experiments carried out in our laboratory showed that adding 5mM Mn2+ in our reaction
buffer and then looking at the processing efficiency with which the 3'-PG containing 14mer was processed, generated an approximately 8 % conversion of 3'-PG to 3'-phosphate
only in the undiluted fraction (Figure 17). This is in agreement with Yang et al. (1996)
who proposed that Tdp1 activity is independent of any co-factor requirement. According
to them, there was no stimulation of Tdp1 activity when reactions were conducted in the
presence of a simple buffer that was supplemented with 10mM Mg, Ca, Co, Cd and Zn.
Tdp1 associates with XRCC1
The XRCC1 gene product is a scaffolding protein containing two BRCA1
carboxyl terminal (BRCT) domains, which are binding motifs for DNA repair and cell
cycle check points (Huyton et al., 2000). XRCC1 is implicated in single strand break
repair pathway (SSBR) (Thompson et al., 2000) and forms a mutimeric repair complex
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Figure 16: No evidence for the presence of other Mg+2 –dependent PG-processing
enzymes
A 3'-phosphotyrosine 18-mer or a phosphorothiaote-substituted 3'-PG 14-mer was treated
with 1 µl of undiluted or 1 µl of seven 1:8 dilutions of JRL 1 whole-cell extract,
containing mutant hTdp1. Each 5µl reaction was incubated at 37 ºC for 2 hours in buffer
with 0.5 mM MgCl2 without EDTA. Samples were boiled for 1 minute at 90 ºC. A final
concentration of 20 mM Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was
assessed by denaturing gel electrophoresis and quantified using ImageQuant software.
There was no conversion to the 3'-OH substrate.
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Figure 17: Effect of 5 mM Mn+2 on hTdp1 activity.
P

P

A 3'-PG 14-mer was treated with 50, 6.25, 0.78, 0.098, 0.012, 0.0015, 0.0002 or
0.000025 ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells. Each
5µl reaction was incubated in buffer containing 50 mM Tris-HCl, pH 8.5/100 mM
NaCl/5 mM MnCl2 /1 mM DTT/ 100 µg/ml BSA at 37 ºC for 15 minutes. Conversion to
3'-phosphate was assessed by denaturing gel electrophoresis and quantified using
ImageQuant software. There was 8 % conversion to 3'-phosphate only in the undiluted
fraction.
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with several enzymes implicated in base excision and gap repair: DNA ligase III
(Caldecott et al., 1994), PARP-1 (Caldecott et al., 1996), PARP-2 (Schreiber et al., 2002),
DNA polymerase β (Kubota et al., 1996), PNKP (Whitehouse et al., 2001) and APE1
(Vidal et al., 2001). Because of this scaffolding property of XRCC1, its possible
association with Tdp1 was tested (Plo et al., 2003). Results showed that Tdp1 coimmunoprecipitated with XRCC1 antibody and that this activity was inhibited in the
presence of sodium vanadate, a reported inhibitor of Tdp1 (Davies et al., 2002). Western
blot analysis also showed the presence of Tdp1 in XRCC1 immuno precipitates. Our
laboratory carried out a western blot analysis using anti-XRCC1 antibody to determine
whether we could detect complexes formed by Tdp1 in cells. We used samples
containing whole cell-extracts, a 1X TE wash obtained during the elution of Tdp1 and
immunoprecipitated FLAG-tagged Tdp1. Our results showed the presence of XRCC1 in
both the whole-cell extract as well as in the sample containing immunoprecipitated Tdp1
while none was present in the wash suggesting that XRCC1 co-precipitates with Tdp1
and a wash with 1X TE does not eliminate their binding (Figure 18a).
XRCC1-complementation enhances Tdp1-activity
To determine whether XRCC1 influenced the repair of topoisomerase I covalent
complexes, Plo and colleagues (2003), incubated a 3'-phosphotyrosine containing 14-mer
with nuclear extracts obtained from XRCC1-deficient (EM9-V) and XRCC1complemented (EM9-XH) cells. Nuclear extracts from XRCC1-deficient (EM9-V) cells
showed reduced processing of the phosphotyrosine substrate to the 14-OH product when
compared to nuclear extracts from XRCC1-complemented (EM9-XH) cells suggesting
that XRCC1 complementation enhances Tdp1 and PNKP activities. When we tried to
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Figure 18a: Tdp1 associates with XRCC1
A western (using Mouse anti-XRCC1 antibody) was carried out with samples containing
50 ng of XRCC1 as a control, 1 µl of whole-cell extract containing FLAG-tagged hTdp1,
10 µl of a TE wash of the whole-cell extract and 2 µl (100 ng) of
IMMUNOPRECIPITATED FLAG-tagged hTdp1. Our results show the presence of
XRCC1 in both the whole-cell extract as well as in the sample containing
immunoprecipitated FLAG-tagged hTdp1 while none was present in the TE wash
suggesting that XRCC1 co-precipitates with Tdp1 and a wash with 1X TE does not
eliminate their binding.
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duplicate these results in our laboratory by incubating 3'-PG containing 14-mer with pure
FLAG-Tdp1 (washed 3 times with salt and then purified with FLAG beads) and different
concentrations of XRCC1, we did not see any marked increase in Tdp1 activity. Yeast
two-hybrid experiments revealed that Tdp1 associates with the single-strand break repair
machinery by direct interaction with DNA ligase IIIα, a partner of XRCC1 (El-Khamisy
et al., 2005). Since, during purification, we washed our extracts in buffer containing high
concentrations of salt, we speculated that ligase III could have been washed away, thus
removing the bridge required for XRCC1 and Tdp1 binding. In order to check for this
possibility, we repeated the above experiment but this time used nuclear extracts derived
from U-87 glioma cells (FLAG-hTdp1 virus-infected cells) instead of purified Tdp1. Our
results indeed showed that with increasing concentrations of XRCC1, Tdp1 activity is
increased (a maximum of ~4 times) before it reaches a plateau (Figures 18b and 18c).
We also carried out a western blot analysis to check for the presence of Ku in
immunoprecipitated extracts. As shown in figure 18d, although a high concentration of
Ku was seen in the control and the whole-cell extracts, there was no indication of coprecipitation of Ku with FLAG-hTdp1 during the latter’s immunoprecipitation, even
though the extracts were washed only with buffer containing1X TE and no salt.
Presence of Tdp1 protein in mitochondrial extracts
Human mitochondria contain approximately 5-10 copies per mitochondrion of a
covalently closed duplex DNA genome (Moraes et al., 2001). Because mitochondrial
DNA molecules are closed circular and therefore topologically constrained, there must be
a mechanism to relieve the DNA strain that arises during replication. Zhang et al. (2001)
reported the existence of a mitochondrial topoisomerase I gene TOP1mt, which is
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Figures 18b and c: Effect of XRCC1 on FLAG-hTdp1 activity
A 3'-PG 14-mer (●) plus 15, 30, 45, 60 or 75 ng of recombinant XRCC1 was added to 1
µl of undiluted nuclear extracts derived from U-87 glioma cells infected with adenovirus
expressing FLAG-hTdp1. Samples (total volume of 5 µl) were incubated for 15 minutes
at 37 ºC in Kedar buffer, followed by boiling of samples at 90 ºC for 1 minute. A final
concentration of 20 mM MgCl2 and 20 ng of PNKP were added and incubation was
continued for 1 hour. Conversion to 3'-OH was assessed by denaturing gel
electrophoresis and quantified using ImageQuant software. Our results showed an
increase in hTdp1 activity (upto 4X) with increasing concentrations of XRCC1.
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Figure 18d: A western blot analysis to check for the presence of Ku in
immunoprecipitated hTdp1 extracts
A western (using Rabbit anti-Ku 70 antibody) was carried out with samples containing
120 ng Ku as a control, 1 µl of whole-cell extract containing FLAG-tagged hTdp1, 10 µl
of a TE wash of the whole-cell extract and 5 µl (250 ng) of immunoprecipitated FLAGtagged hTdp1. Although, a high concentration of Ku was seen in the control and the
whole-cell extracts, there was no indication of co-precipitation of Ku with FLAG-hTdp1
during the latter’s immunoprecipitation, even though the extracts were washed only with
buffer containing1X TE and no salt.
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localized on human chromosome 8q24. They found a high degree of homology between
top1mt and nuclear topo1 which was further demonstrated by the top1mt protein being
sensitive to CPT treatment (Tua et al., 1997), thus generating DNA strand breaks by
blocking the re-ligation of topo1-linked DNA breaks. The formation of the mitochondrial
topo1-DNA covalent complex lead us to speculate the presence of Tdp1 within the
mitochondria to repair topoI-linked breaks as well as DSBs with 3′-PG termini that might
arise as a result of oxidative stress. Western blot analysis using samples containing Tdp1
purified from whole-cell extracts (as a control), mitochondrial extract (from GM1310
normal human fibroblasts; gift of Penelope Mason, National Institute of Aging), wholecell and mitochondrial extracts from the SCAN 1 cell-lines JRL 5 (containing wild-type
Tdp1) and JRL 3 (containing mutant Tdp1) using anti-Tdp1 antibody indeed showed
presence of a high concentration of hTdp1 in the mitochondrial extract derived from the
GM1310 cell-line (Figure 19). While the whole-cell extracts from both the SCAN1 celllines seemed to contain hTdp1, along with some quantity of degradation products, only
the mitochondrial extracts from JRL 5 cells showed the presence of hTdp1.
Mitochondrial extracts show similar PG-processing efficiency as whole-cell extracts
We incubated serial 1:8 dilutions each of whole-cell extracts (without
mitochondria) and mitochondrial extracts with an 18-mer containing 3'-phosphotyrosine
for 15 minutes at 37°C and our results showed that there was no marked difference in the
processing efficiencies between the extracts. When we carried out similar experiments
using a 14-mer with 3'-PG, we found the same result, i.e., the difference in processing of
the phosphotyrosine vs. PG oligomers was similar for both the whole-cell and
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Figure 19: Western Blot analysis of whole-cell and mitochondrial extracts derived
from GM1310 normal human fibroblasts and SCAN1 cells.
A western blot was carried out using 2 µl (100 ng) of FLAG-hTdp1, purified from
adenovirus infected U-87 glioma cells, 2 µl of mitochondrial extract derived from
GM1310 cell-line, 10 µl of whole-cell extracts as well as 5 µl of mitochondrial extracts
from the SCAN1 cell-lines, JRL 3 (mutant hTdp1) and 5 (wild-type hTdp1) respectively.
The blot showed a high concentration of hTdp1 protein in the mitochondrial extract
derived from the GM1310 cell-line. While the whole-cell extracts from both the SCAN1
cell-lines seemed to contain hTdp1, along with some quantity of degradation products,
only the mitochondrial extracts from JRL 5 cells showed the presence of hTdp1.
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Figure 20: Relative end-processing efficiencies of whole-cell vs. mitochondrial
extracts derived from GM1310 normal human fibroblasts.
1 µl of undiluted or1 µl of five 1:8 dilutions of each of the whole-cell extracts and the
mitochondrial extracts were incubated with 18-mer containing 3’-phosphotyrosine (●) or
the 14-mer containing 3’-PG (○) for 15 minutes at 37° C in Kedar buffer containing 5
mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final concentration of 20 mM
Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel
electrophoresis and quantified using ImageQuant software. Both whole-cell extracts and
mitochondrial extracts showed comparable phosphotyrosine and PG-processing activities.
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mitochondrial extracts suggesting that the specificity of mitochondrial Tdp1 is very
similar to the nuclear protein and that mitochondrial extracts contain Tdp1 at a
concentration comparable to whole-cell extracts (Figure 20).
Processing efficiencies of JRL 5 (wild-type Tdp1) and JRL 3 (mutant Tdp1)
mitochondrial extracts
Consistent with the above western blot analysis, when we compared the efficiency
with which various 1:8 dilutions of the JRL 5 and the JRL 3 mitochondrial extracts
process a 3'-phosphotyrosine containing 18-mer and a 3'-PG containing 14-mer, we found
that while there was absolutely no conversion to 3'-OH with the JRL 3 mitochondrial
extract, our results did show ~ 34% and ~ 15% conversion from 3'-phosphotyrosine to the
3'-OH product with the undiluted and the first 1:8 diluted JRL 5 mitochondrial extracts
respectively adding further evidence that all PG-processing activity in mitochondria is
attributable to hTdp1. Neither the JRL-3 nor the JRL-5 mitochondrial extract showed any
activity with the 3'-PG containing oligomer (Figure 21), consistent with the low level of
phosphotyrosyl processing seen in the JRL-5 extract and the relative inefficiency of Tdp1
in processing PG substrates.
Processing of a 3'-PG oligomer is partially inhibited by Ku
The Ku heterodimer, consisting of a tight complex of Ku70 and Ku80, forms a
close-fitting asymmetrical ring that threads onto the free end of DNA as a nut in a bolt
(Walker et al., 2001). Although Ku tends to cling to DNA ends, it can translocate to the
interior of the DNA, thus allowing multiple Ku heterodimers to load onto longer DNA
molecules (Yaneva et al., 1997). Ku purified from human placenta by MonoQ
chromatography also showed the presence of substantial 3'-phosphotyrosine processing
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Figure 21: Relative end-processing efficiencies of JRL 3 and 5 mitochondrial
extracts
An 18-mer containing 3’-phosphotyrosine or a 14-mer containing 3’-PG was treated with
1 µl of undiluted or1 µl of seven 1:8 dilutions of each of the mitochondrial extracts
derived from JRL 3 and 5 cell-lines for 15 minutes at 37° C in Kedar buffer containing 5
mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final concentration of 20 mM
Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel
electrophoresis and quantified using ImageQuant software. Our results showed ~ 34%
and ~ 15% conversion from 3'-phosphotyrosine to the 3'-OH product with the undiluted
and the first 1:8 diluted JRL 5 samples respectively and absolutely no conversion to 3'OH with the JRL 3 mitochondrial extract.
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activity (Inamdar et al., 2002). This association of glycolate removing activity with
human placental Ku raised the possibility that Ku may bind to Tdp1 and recruit it to the
DNA ends. When we compared the efficiencies with which this purified Ku processes
both a 3'-phosphotyrosine containing 18-mer and a 3'-PG containing 14-mer, we found
that there was a 10-fold difference similar to that of human Tdp1 partially purified from
lymphoblastoid while-cell extracts (figures 22a and 22b). Although Ku does not bind to
single-stranded substrates, binding of Ku to Tdp1 could modify its specificity. To
examine this possibility, hTdp1-catalyzed tyrosine and glycolate removal from the 18mer with 3'-phosphotyrosine and the14-mer with 3'-PG respectively, was assayed in the
presence and absence of 20 ng of recombinant Ku, which unlike the human placental Ku,
was free of any PG-processing activity. As shown in figures 23a and 23b, the effect of
recombinant Ku was inhibitory i.e., the presence of recombinant Ku decreased the
susceptibility of both substrates to hTdp1-mediated processing (compare to Fig 14).
However, phosphotyrosyl processing was inhibited more than the PG-processing, so that
in the presence of Ku the ratio of processing efficiencies was reduced from 100-fold to
26-fold. This result suggests possible interaction between hTdp1 and Ku.
Processing of a double-stranded substrate with 3'-PG overhang is partially inhibited
by Ku
Since Ku is part of the repair complex that repairs DSBs via the NHEJ pathway,
we looked at the effect of Ku on hTdp1 activity using a double-stranded substrate with a
3'-PG-terminated 3' overhang. The substrate was pre-incubated with various dilutions of
recombinant Ku for 5 minutes to allow binding to the open end of the substrate followed
by incubation with hTdp1 for 10 minutes to allow PG-processing. Following boiling of
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Figure 22a and b: Processing of a 3'-PG oligomer by Ku derived from placental
tissue
A 3'-phosphotyrosine 18-mer (●) or a 3'-PG 14-mer (○) was treated with 170, 21.25,
2.65, 0.33, 0.042, 0.0052 or 0.00065 ng of Ku, purified from placental tissue by MonoQ
chromatography. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. 20 mM Mg2+ and 20
ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel
electrophoresis and quantified using ImageQuant software. The relative end-processing
efficiencies was found to be approximately 10-fold.
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Figure 23a and b: Processing of 3'-PG and 3'-phosphotyrosine oligomers by hTdp1
in the presence of recombinant Ku
A 3'-phosphotyrosine 18-mer (●) or a 3'-PG 14-mer (○) was treated with 20 ng of
recombinant Ku, commercially obtained from Trevigen, Inc., and 50, 6.25, 0.78, 0.098,
0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from adenovirus infected U-87
glioma cells. The sample without Ku contained 50 ng of FLAG-hTdp1. Each 5µl reaction
was incubated at 37 ºC for 15 minutes in Kedar buffer containing 5 mM EDTA. Samples
were boiled for 1 minute at 90 ºC. 20 mM Mg2+ and 20 ng hPNKP were added.
Conversion to 3'-OH was assessed by denaturing gel electrophoresis and quantified using
ImageQuant software. The difference in end-processing efficiencies for the two
substrates was found to be approximately 26-fold.
P

P

112

Figure 23a
+

+

+

+

+

+

-

Ku

hTdp1
18-Y
18-OH

14-OH
14-PG

Figure 23b

100

% conversion

80

18-Y
60

26-FOLD
40

14-PG
20

0
1e-5

1e-4

1e-3

1e-2

1e-1

Log Dilution

1e+0

1e+1

113
PG terminus to hTdp1 when Ku is bound to the DNA end or direct interaction between
hTdp1 and Ku. However, there is no evidence that Ku recruits hTdp1 to DNA ends or
facilitates hTdp1-mediated end processing (Figures 24a and 24b).
Since our results showed that Ku inhibited Tdp1, we carried out similar
experiments with very high concentrations of a truncated form of Ku in order to see if
these high concentrations inhibited the activity of Tdp1 completely. This truncated form
lacks a carboxy-terminal 19K domain known to function in DNA-PK recruitment, but
which is dispensable for DNA end binding (Wlaker et al., 2001) and observed that 1 µg
concentration of truncated Ku inhibited the FLAG-hTdp1 activity by nearly 80% (Figure
24c).
Processing of the double-stranded substrate with 3'-PG overhang is partially
inhibited by Ku-DNA-PK and Ku-DNA-PK-XRCC4/ligase IV complexes.
On comparing the processing efficiency of samples in which both Ku and DNAPK were incubated with the double-stranded substrate containing a 3'-PG overhang with
that of samples in which DNA-PK was pre-incubated alone, we observed that the ability
to process PGs by Tdp1 in samples with both Ku and DNA-PK was inhibited more than
in samples with DNA-PK alone (Figures 25a and 25b). Similar results were observed
when XRCC4/ligase IV was added to the complex i.e. samples containing Ku, DNA-PK
and XRCC4/ligase IV inhibited Tdp1 activity more than samples containing DNA-PK
and XRCC4/ligase IV only (Figures 26a and 26b). These data again suggest that once the
end-joining repair complex is formed on DNA ends, end processing by Tdp1 is at least
partially inhibited.
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Figure 24a and b: Effect of different dilutions of Ku on FLAG-hTdp1 activity.
A double-stranded plasmid with a 3'-PG overhang was pre-incubated with 15, 30, 45, 60
or 75 ng (15 ng = 100fmoles) of recombinant Ku, obtained from Trevigen, Inc., for 5
minutes in Kedar buffer followed by incubation with 0.78 ng of FLAG-hTdp1, purified
from adenovirus infected U-87 glioma cells, for 10 minutes to allow PG-processing.
Following boiling of the samples at 90°C for 2 minutes, the substrate was incubated with
1000 units/ mL CIP for 1 hour at 37°C for removal of phosphate group. The samples
were again heated at 90°C for 5 minutes and then incubated with Taqα1 for 3 hours at
65°C to yield a 15-mer with the 3'-OH. Our results showed that increasing concentrations
of Ku had an inhibitory effect on hTdp1 activity.
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Figure 24c: Effect of different concentrations of truncated Ku on FLAG-hTdp1
activity
A double-stranded plasmid with a 3'-PG overhang was pre-incubated with 20, 50, 100,
200, 400 or 1000 ng of recombinant truncated Ku for 5 minutes followed by incubation
with 0.78 ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells, for
10 minutes to allow PG-processing. Following boiling of the samples at 90°C for 2
minutes, the substrate was incubated with CIP for 1 hour at 37°C for removal of
phosphate group. The samples were again heated at 90°C for 5 minutes and then
incubated with Taqα1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our results
showed that increasing concentrations of Ku had an inhibitory effect on hTdp1 activity.
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Effect of different dilutions of Ku-DNA-PK complex on FLAG-hTdp1 activity
Figure 25a- A double-stranded plasmid with a 3'-PG overhang (2 fmoles) was preincubated with 27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of
DNA-PK for 5 minutes at 25 °C followed by incubation with 0.78 ng of FLAG-hTdp1,
purified from adenovirus infected U-87 glioma cells, for 10 minutes in Ramsden buffer
containing 100 µM ATP and 5 mM MgCl2 to allow PG-processing. After boiling of the
samples at 90°C for 2 minutes, the substrate was incubated with CIP for 1 hour at 37°C
for removal of phosphate group. The samples were again heated at 90 °C for 5 minutes
and then incubated with Taqα1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our
results showed that samples containing Ku and DNA-PK inhibited Tdp1 activity more
than samples containing DNA-PK only.
Figure 25b: The experiment was carried out in triplicates; each showing a similar result.
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Effect of different dilutions of Ku-DNA-PK-XRCC4/ligase IV complex on FLAGhTdp1 activity
Figure 26a: A double-stranded plasmid with a 3'-PG overhang was pre-incubated with
27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of DNA-PK for 5
minutes at 25 °C followed by pre-incubation with 10 nM XRCC4/ligase IV (50 fmoles)
for 5 minutes at 25 °C. reactions were carried out in Ramsden buffer containing 100 µM
ATP and 5 mM MgCl2. A control experiment in which the double-stranded plasmid was
incubated with DNA-PK and XRCC4/ligase IV was also simultaneously carried out. 0.78
ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells, was added for
10 minutes to allow PG-processing. Following boiling of the samples at 90°C for 2
minutes, the substrate was incubated with CIP for 1 hour at 37°C for removal of
phosphate group. The samples were again heated at 90 °C for 5 minutes and then
incubated with Taqα1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our results
showed that samples containing Ku, DNA-PK and XRCC4/ligase IV inhibited Tdp1
activity more than samples containing DNA-PK and XRCC4/ligase IV only.
Figure 26b: the experiment was carried out in triplicates; each showing similar results.
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Inhibition of DNA-PK autophosphorylation does not show a marked inhibition on
Tdp1 activity.
Chan et al. (2002) and Soubeyrand et al. (2003) indicated that cellular end-joining
requires DNA-PKcs to undergo autophosphorylation. They showed the presence of six
autophosphorylation sites clustered within a 40-amino acid region. Later, Reddy et al.
(2004) showed that autophosphorylation at these six sites uniquely makes DNA ends
accessible while still allowing DNA-PKcs to persist at ends and retain XRCC4-ligase IV
within a complex at the ends. Their results indicate that autophosphorylation of the six
sites leads to a destabilization of DNA-PK that is critical for significant end-joining
activity. Therefore, they propose that autophosphorylation within the six sites is uniquely
able to direct a rearrangement of the DNA-PK complex at DNA ends that is essential for
end-joining both in vitro as well as in cells. Based on this information, we looked at the
effect of autophosphorylation of DNA-PK on Tdp1 activity. We assumed that since,
according to Reddy and colleagues, autophosphorylation destabilizes DNA-PK and
increases cellular end-joining, inhibition of autophosphorylation would stabilize the
DNA-PK on the DNA ends, thus markedly inhibiting the Tdp1 activity. But our results
showed that the presence of ATP (Figures 25a and b) resulted in only a slight reduction in
the inhibition caused by presence of DNA-PK at the DNA ends. Thus based on results
with purified proteins, autophosphorylation of DNA-PK does not appear to play a major
role in regulating accessibility of DNA ends to hTdp1 (Figures 27a and 27b). it is
possible that the putative conformational change in DNA-PK that is induced by
autophosphorylation has a greater effect on the susceptibility of DNA ends to
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exonucleolytic degradation (which was assayed by Reddy et al) than to simple glycolate
removal by Tdp1.
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Effect of inhibition of autophosphorylation of DNA-PK on hTdp1 activity.
Figure 27a: A double-stranded plasmid with a 3'-PG overhang (2 fmoles) was preincubated with 27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of
DNA-PK for 5 minutes at 25 °C followed by incubation with 0.78 ng of FLAG-hTdp1,
purified from adenovirus infected U-87 glioma cells, for 10 minutes in Ramsden buffer
without ATP and Mg+2. A control experiment in which the double-stranded plasmid was
incubated with DNA-PK and FLAG-hTdp1 alone was also simultaneously carried out.
After boiling of the samples at 90°C for 2 minutes, the substrate was incubated with CIP
for 1 hour at 37°C for removal of phosphate group. The samples were again heated at 90
°C for 5 minutes and then incubated with Taqα1 for 3 hours at 65°C to yield a 15-mer
with the 3'-OH. Our results showed did not show a dramatic inhibition of hTdp1 activity
as was expected.
Figure 27b: The experiment was carried out in triplicates; each showing a similar result.
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Figure 27b
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Discussion

The main conclusions of this study are- 1. Altered specificity of Tdp1 in extracts vs.
recombinant Tdp1 is due to interactions with other proteins rather than post-translational
modification. 2. There was no detectable binding of NHEJ proteins with Tdp1 by western
blot analysis. 3. All NHEJ proteins alone or in combination inhibited Tdp1 activity on 3‘overhangs. 4. Mitochondria contain PG and phosphotyrosine processing activity
attributable to Tdp1.
DSBs induced by radiomimetic antibiotics such as neocarzinostatin and
calicheamicin typically have PG-terminated 3′ overhangs at one end of the break (Giloni
et al., 1981). About half of radiation-induced strand breaks also have 3′-PG termini
(Henner et al., 1983), and many of these are presumably on 3′ overhangs of DSBs. In the
repair of such lesions, removal of the 3′-PG termini must necessarily precede any
polymerase-mediated gap filling and/or religation of the DSB. However, while the human
apurinic/apyrimidinic endonuclease Ape1 can remove PGs, albeit inefficiently, from
blunt and recessed 3′ termini of DSBs, PGs on 3′ overhangs are completely refractory
(Suh et al., 1997). The human polynucleotide kinase/phosphatase PNKP, which removes
3′ phosphates from single-stranded 3′ termini (Jilani et al., 1999), also had no detectable
effect on 3′-PGs (Inamdar et al., 2002), just as was previously reported for rat
polynucleotide kinase/phosphatase (Habraken et al., 1988). The susceptibility of 3′-PGs
to E.coli exonuclease I (Sandigursky et al., 1993) raised the possibility that PGs on 3′
overhangs might be removed by a mammalian 3′-> 5′ exonuclease. However, DNase III,
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which is the dominant 3′->5′ exonuclease in mammalian cell extracts, has no detectable
effect on any 3′-PG substrates (Inamdar et al., 2002). The Wrn1 and Mre11 3′->5′
exonucleases are also unlikely candidates because both show a strong preference to
recessed 3′ termini and 3′ overhangs, even if unblocked, are resistant to these enzymes
(Kamath-Leob et al., 1998, Huang et al., 2002). The Sacchromyces cerevisiae
Rad1/Rad10 endonuclease (and presumably its human ERCC1/XPF homolog) can
remove a single 3′-PG (or 3′-OH) nucleotide from the 3′ end of a single-strand break in
double-stranded DNA (Guzder et al., 2004), but no such activity has been reported on
PG-terminated 3′ overhangs. Similarly, while Artemis, a DNA-PK activated
endo/exonuclease, has been implicated in DSB repair (Moshous et al., 2001), this enzyme
appears to act only on 3′-overhangs longer than 4 bases (Ma et al., 2002). Nevertheless,
PGs on overhanging 3′ termini clearly are processed in Xenopus, human and hamster cell
extracts (Ma et al., 2002).
Evidence for a 3′-phosphate intermediate in 3′-PG removal in human cell extracts
(Inamdar et al., 2002) suggested possible involvement of hTdp1, and indeed, experiments
carried out in our laboratory showed that both hTdp1 and scTdp1 were found to catalyze
similar glycolate removal from a single-stranded oligomer as well as from a single-strand
overhang of a DSB. Failure to detect this activity in previous studies could have been due
to the very small difference in electrophoretic mobility between 3′-PG and 3′-phosphate
oligomers and the relative inefficiency of PG processing by recombinant hTdp1
compared to its normal substrate, 3′-phosphotyrosine.
DSBs generated by ionizing radiation cannot be repaired by simple ligation
because end joining is more complex due to the presence of fragmented sugars and
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damaged or missing nucleotides at DNA ends. DNA treated with antibiotic bleomycin
(Giloni et al., 1981) or exposed to IR (Henner et al., 1983) contains DSBs formed by
sugar oxidation and fragmentation. Free radical-mediated oxidation of the C-4′ position
of the deoxyribose in DNA results in sugar fragmentation and strand cleavage, releasing
base propenal and leaving the two-carbon fragment-PO4CH2COOH, or PG, linked to the
B

B

B

B

3′-end of the break. These end groups will block the activities of DNA polymerase and
DNA ligase enzymes (Noguti et al., 1975). About half of radiation-induced strand breaks
have 3′-PG termini and many of these are presumably on 3′-overhangs of DSBs. In the
repair of such lesions, removal of the 3′-PG termini must necessarily precede any
polymerase-mediated gap filling and/or religation of the DSB. Strand breaks with
modified 3-termini are two times more toxic than their 3′-OH counterparts (Kow et al.,
1991).
Tyrosyl DNA phosphodiesterase (Tdp1) is the only enzyme known so far to
function in DNA repair and remove blocks to leave 3′--phosphate ends. Our results
showed that both yeast and human Tdp1 processed PG substrates efficiently and gave rise
to 3′-phosphate product corresponding to a band that migrated between the PG and
hydroxyl bands. Thus, Tdp1 is capable of selectively removing the glycolate from PG to
leave behind 3′-phosphate ends that are efficiently converted to hydroxyl ends by PNKP
as indicated by generation of a 3′-OH when the substrate was incubated with both the
enzymes together. The crystal structure of hTdp1 (Davies et al., 2002) shows the
presence of an active site in the enzyme consisting of histidine and lysine residues that
are conserved in the HKD motif of phospholipase D superfamily of proteins, of which
Tdp1 is a member. These residues lie close to a 40A long cleft that runs along one surface
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of the protein. The active site is in the center of a 2-fold axis of symmetry between two
domains in the enzyme. Based on structural and biochemical data, the conserved PLD
superfamily reaction mechanism has been proposed to consist of two consecutive SN2
substitutions (Interthal et al., 2005). In the first step of the reaction, a histidine residue in
the N-terminal HKD motif (His263) is proposed to carry out a nucleophilic attack on the
phosphorous atom in the phosphodiester bond between the tyrosine residue and the DNA
3′ oxygen to become covalently attached to the 3′ end of the DNA via a phosphoamide
bond to the Nε2 atom of the nucleophilic His263 (Davies et al., 2003 and Raymond et al.,
2004). In the final step, hydrolysis of this intermediate is believed to be carried out by a
water molecule that is activated by His493 from the C-terminal HKD motif acting as a
general base. This Tdp1 catalysis thus produces free tyrosine and a DNA with a 3′phosphate end. Thus, it is tempting to speculate here that a histidine residue from one
domain of the active site could carry out a nucleophilic attack on the phosphorous from
the PG group thus leading to the dissociation of glycolate to leave behind 3′-phosphates.
The PG substrate however, required a higher concentration of the enzyme (scTdp1 as
well as hTdp1) than the control phosphotyrosine substrate. The crystal structure of the
enzyme as well as its mode of action on the topoisomerase I-DNA complexes may help
to explain this difference in substrate specificity. The topoisomerase I-DNA
phosphodiester bond is buried deep inside the covalent complex (Davies et al., 2002) and
topoisomerase I needs to be degraded and the DNA unwound for easy access and
efficient functioning of the enzyme. Therefore, DNA unwinding as well as the presence
of a protein at the end of the DNA, both may be necessary pre-requisites for optimal
functioning of the enzyme. The PG substrate lacks this protein-DNA configuration at its
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end. This difference in end-structure of the substrate may account for the lower efficiency
of Tdp1 on PG substrates. Since our experiments provided no evidence that the low
activity of the recombinant enzyme on the PG substrates when compared to crude or
fractionated cell extracts was due to lack of proper post-translational modifications,
presence of the N-terminal epitope tag, or degradation or alteration of the recombinant
protein during its preparation, we can speculate that the apparent increase in the inactivity
of the native protein toward PG substrates may be the effect of its interactions with other
repair factors in the extracts.
Although Cheng et al. in 2002 proposed that Mn2+ has a stimulatory effect on
Tdp1 activity, our experiments showed that adding 5mM Mn2+ in our reaction buffer did
not show any increase in PG-processing activity of hTdp1. This is in agreement with
Yang et al. (1996) who proposed that Tdp1 activity is independent of any co-factor
requirement. According to them, there was no stimulation of Tdp1 activity when
reactions were conducted in the presence of a simple buffer that was supplemented with
10mM Mg, Ca, Co, Cd and Zn. Experiments conducted in our laboratory also showed
that both crude extracts as well as purified Tdp1 (both yeast and human) processed PGs
in the presence of EDTA suggesting that glycolate removal was independent of co-factor
requirement.
Human mitochondria contain ~5-10 copies per mitochondrion of a covalently
closed duplex DNA genome (Moraes et al., 2001). Because mitochondrial DNA
molecules are closed circular and therefore topologically constrained, there must be a
mechanism to relieve the DNA strain that arises during replication. Zhang et al. (2001)
reported the existence of a mitochondrial topoisomerase I gene TOP1mt, which is
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localized on human chromosome 8q24. They found a high degree of homology between
top1mt and nuclear topo1 which was further demonstrated by the top1mt protein being
sensitive to CPT treatment (Tua et al., 1997), thus generating DNA strand breaks by
blocking the re-ligation of topo1-linked DNA breaks. The formation of the mitochondrial
topo1-DNA covalent complex lead us to speculate that Tdp1 within the mitochondria
may be involved in repair of DSBs with 3′-PG termini that might arise as a result of
oxidative stress. Indeed our western blot analysis of mitochondrial extracts from the GM
cell line showed the presence of Tdp1. Our substrate processing assays also show that
both the whole-cell and mitochondrial extracts have comparable PG and tyrosine
processing efficiencies suggesting that mitochondrial Tdp1 is as abundant as its
cytoplasmic counterpart.
DNA DSB repair in vertebrate cells occurs mainly by the mechanism of nonhomologous end-joining. This phenomenon was first demonstrated in CV1 monkey
kidney cells by transfecting into them a plasmid with a polylinker inserted in the intron of
SV 40 T-antigen. Prior to transfection, the polylinker was restriction digested with
various enzymes to create linear DNA with mismatched ends (Roth and Wilson, 1986).
Analysis of repair joints formed by the system from linearized plasmids revealed that
ends with non-complementary or partially complementary 3′ and 5′-overhangs were in
many cases efficiently joined via post-repair ligation without loss of any nucleotides at
their termini. This ligation involved alignment of short partial complementarities from
each single-stranded extensions to create gaps in both single strands to be filled in by a
polymerase to create ligatable nicks. Similar experiments using Xenopus extracts
(Pfeiffer et al., 1994) supported this post-repair ligation process whereby protruding

135
DNA ends are held in alignment during processing of mismatched 3-overhangs followed
by fill-in synthesis. These experiments suggested the existence of alignment factor(s) to
properly align the protruding single-strand tails in short overlaps as well as to hold
abutting ends in juxtaposition. Petra Pfeiffer et al. provided a direct evidence for
existence of such an alignment factor by showing that the efficiency and accuracy of
NHEJ is dramatically reduced in xrs6 extracts deficient in Ku 70/80 heterodimer and that
the lack of accuracy was due to inability to align the two broken ends for DNA fill-in
synthesis (Feldmann et al., 2000). These results imply that Ku plays a critical role in
aligning the two broken ends together and protecting the overhangs during end-joining.
Further proof came from experiments that showed that Ku actively binds the ends of
DNA DSBs and promotes association of the DNA ends with each other (Pang et al.,
1997). One heterodimer binds to each end and the two heterodimers interact with each
other (Cary et al., 1997), thereby bridging the two DNA ends. This serves to protect the
ends from processing and degradation as well as accounts for stimulation of
intermolecular ligation by eukaryotic ligases (Ramsden and Gellert, 1998). DNA-PKcs
associates with the Ku heterodimer and is recruited to the DNA ends by Ku which then
activates its kinase function Featherstone and Jackson, 1999). A number of proteins can
be phosphorylated by DNA-PK but the significance of this phosphorylation is not clear.
Several observations, including its ability to associate with and phosphorylate Artemis
thus, activating the latter’s endonuclease activity (Ma et al., 2002), suggest a specific role
for DNA-PKcs in directing end-processing events; however, DNA-PKcs deficiency
affects cellular end-joining even when processing is not required (Bogue et al., 1998). A
more general role for DNA-PKcs in end-joining is also consistent with in vitro evidence
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indicating that it helps Ku recruit the XRCC4-ligase IV complex to DNA ends (Chen et
al., 2000) and promotes the intermolecular synapsis of two the DNA ends (DeFazio et al.,
2002). Together, these functions of DNA-PKcs may explain why XRCC4-ligase IV
activity is necessary in vitro when using substrates that do not require processing
(Hanakahi et al., 2000).
Valerie and Povirk (2003) proposed an in vitro model for the NHEJ repair
pathway. According to their proposal, DNA DSBs induced by IR or bleomycin with 3′PGs are first recognized by Ku heterodimer. Upon binding to the ends, Ku properly
positions itself such that it bridges the two ends and aligns them together for repair to
proceed by fill-in and ligation. Ku then recognizes the PG groups at the ends and recruits
hTdp1 and PNKP, which then effectively carry out the conversion of PG to glycolate to
hydroxyl ends in sequential and well-coordinated steps. The hydroxyl ends are bound and
protected by Ku until it recruits DNA-PKcs, which displaces Ku ~10 base pairs to the
interior of the DNA from the ends so that its can properly align itself at the end. DNA-PK
then recruits and phosphorylates additional proteins such as exonucleases, Artemis and
XRCC4/DNA ligase IV to the ends to form the NHEJ repair complex. DNA-PK finally
undergoes autophosphorylation and removes itself from the ends to allow fill-in and religation. But experiments conducted in our laboratory did not show any evidence for the
above model. In our experiments, when purified Ku alone was pre-incubated with
substrates followed by addition of Tdp1, Ku had an inhibitory effect on the removal of
glycolate by Tdp1. If Ku did recruit Tdp1, then there should have been an increase in the
latter’s activity, not a marked inhibition. Ku is known to bind to the broken DNA ends
and protect them from degradation by nucleases. The inhibitory effect of Ku on Tdp1 is
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in agreement with this well acknowledged function of Ku. It is possible that Tdp1
actually processes the DNA ends even before Ku binds to it. It is also possible that in the
presence of Ku, DNA cannot be properly threaded into the DNA binding cleft on Tdp1
protein. Cross-linking studies (Yoo and Dynan, 2000) show that when DNA-PK is
recruited to the ends, Ku moves to the interior of the DNA, facilitating the binding of
DNA-PK. Our Tdp1 activity assays comparing the processing of a plasmid substrate
containing 3′-PG overhang by samples in which Ku-DNA-PK complex was preincubated versus samples in which DNA-PK was pre-incubated alone showed that when
both Ku and DNA-PK are present together, there is more inhibition of Tdp1 activity than
with DNA-PK alone. Therefore, though theoretically there was a possibility that once Ku
moves interior, the positioning of DNA-PK on the DNA molecule may actually facilitate
the access of Tdp1 to the PG groups, our results showed otherwise. One would also
predict that autophosphorylation of DNA-PK, which is required for its removal from the
DNA-ends, would facilitate Tdp1 activity but once again, our results from experiments
conducted without addition of ATP, did not show a marked inhibition of Tdp1 activity
which should have been brought about if the ends were blocked by DNA-PK. The preincubation of three of the NHEJ key proteins-Ku, DNA-PK and XRCC4-ligase IV also
produced a high inhibition of Tdp1 activity. Because of this suppression of Tdp1 activity
by DNA-PK, it is tempting to speculate here that such a suppression may require the
synapsis of two DNA/DNA-PK complexes (Hammarsten et al., 2000). In intact cells, the
bringing together of two broken DNA ends could be quite a slow and complex process
(DiBiase et al., 2000), and thus the ability or inability of DNA-PK to protect lone DNA
ends from processing could strongly affect the ultimate nature and fidelity of repair.
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Takashima et al. (2002) observed that mutation of Tdp1 is associated with
spinocerebellar ataxia with axonal neuropathy (SCAN1). The association of this DNA
repair protein with SCAN1 is striking in that this is a disease characterized by
neurodegeneration but which lacks any obvious extra neurological features such as
genetic instability or cancer. Although not proven, it is generally assumed that SCAN1
pathology is a consequence of the failure of mutant Tdp1 to efficiently repair topo1associated DNA damage (Takashima et al., 2002). This repair deficiency could indirectly
confer sensitivity to oxidative damage, as certain oxidative lesions tend to promote
formation of topo1 cleavable complexes (Pourquier et al., 1999), which upon replication
can be converted to cytotoxic topo1-terminated DSBs (Hsiang et al., 1989). Previous
experiments in our laboratory showed that in extracts of SCAN1 cells harboring mutant
Tdp1, there was no detectable processing of a PG terminus on a three-base 3′-overhang
formed by free radical-mediated DNA cleavage (Zhou et al., 2005). Because a substantial
proportion of DNA breaks induced by ionizing radiation bear 3′-PG termini (Henner et
al., 1983), cells deficient in processing of PG-terminated DSBs were expected to be
profoundly radiosensitive. However, Zhou et al. (2005) showed that, in cell growth
assays, only slight radiosensitivity was detected in two of three SCAN 1 cell lines, and
then only for fractionated radiation in plateau phase. These results suggest that most PGterminated DSBs are still repaired in SCAN1 cells, presumably by Tdp1-independent
pathways. Blunt and recessed 3′-PG ends could be processed by Ape1, while 3′overhangs longer than four bases could be processed by Artemis. Thus, the fraction of
radiation-induced DSBs that strictly require only Tdp1 for repair may be very small,
possibly less than 10%. Even for these breaks, there may be an alternative, more
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complicated pathway that can substitute when simpler end-joining pathways fail, as
suggested by the ‘repair foci’ of DSB repair factors that can be detected cytologically
long after majority of DSBs have already been repaired (Bradbury et al., 2003). Whether
protruding PG termini on DSBs are more persistent in SCAN1 than in normal cells in
vivo is not known, and although a post-labeling assay for PG-formation and repair in vivo
has been described previously (Weinfeld et al., 1991 and Bertoncini et al., 1995), this
assay is relatively insensitive and does not distinguish between SSB and DSB termini. To
investigate the molecular basis of SCAN1, El-Khamisy et al. (2005) carried out both
quantitative γ-H2AX immunostaining and neutral comet assays. When both of these
experiments failed to reveal a measurable difference between the level of DSBs in nonreplicating normal and SCAN1 cells, they suggested that more than 98% of the breaks
that occur accumulate in non-replicating SCAN1 cells are SSBs (El-Khamisy et al.,
2005). Topoisomerase I transiently generates SSBs as a part of its normal catalytic cycle,
during which it becomes covalently attached to the 3′- terminus of the break until the
SSB is subsequently resealed by the topoisomerase (Wang et al., 2002). With regard to
the source of SSBs in SCAN1 cells, replication-independent topo1-associated SSBs can
arise by collision of cleavage complexes with RNA polymerases or by close proximity
with other DNA adducts (Pommier et al., 2003). While a loss of Tdp1 function in DSB
repair results in little or no observable phenotype in replicating tissues, how does loss of
Tdp1 cause a dramatic phenotype in non-replicating neurons? To address this question,
El-Khamisy et al. (2005) mimicked the postmitotic state of neurons by arresting mitosis
in lymphoblastoid cells from SCAN1 patients and then exposed the cells to the Topo1
poison, camptothecin. Campothecin treatment caused abundant SSBs in the DNA. When
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camptothecin was removed, SCAN1 cells did not repair the breaks whereas wild-type
cells did so rapidly. Importantly, SSBs induced by oxidative stress, another DNA
damaging agent, also were inefficiently repaired in SCAN1 cells. Additional yeast twohybrid, co-immunoprecipitation, and reconstitution studies showed that normal human
cells possess a novel Tdp1-dependent SSBR process (consisting of Tdp1, XRCC1, PNKP
and Ligase IIIα) that rapidly repairs topo1-SSBs, and that this process is absent in
SCAN1 cells. Consistent with this information, western blot analysis carried out by our
laboratory indeed showed the presence of XRCC1 in purified Tdp1 extract (washed once
with 1X TE prior to elution), adding further proof to statements made by El-Khamisy and
colleagues. Our processing assays with nuclear extracts obtained from adenovirusinfected U87 cells showed that XRCC1 was found to enhance Tdp1 activity up to 4X.
Keeping this information in mind, it would be interesting to check if mutated Tdp1 binds
to XRCC1 at all; if there is no evidence of binding then it would be tempting to speculate
that the binding site for XRCC1 is contained within the mutation.
Yet another role for Tdp1 in SCAN1 was presented by Interthal et al. (2005) who
stated that, in combination with 3′-PG as a substrate, Tdp1 may also function to remove a
variety of 3′ adducts including those that contain a 3′-biotin or a 3′-abasic site. Using a
tryptic peptide of Tdp1 H493R (mutant form of Tdp1 in SCAN1) bound to the 3′-end of
an oligonucleotide as a substrate for wild-type Tdp1, their data showed that Tdp1 is
capable of hydrolyzing the phosphamide linkage between the peptide and the DNA. They
observed that unlike the native topo1-DNA complex, which is not a substrate for Tdp1,
Tdp1 removed a fully folded Tdp1 enzyme from the DNA. They speculated that Tdp1
somehow promotes sufficient unfolding of the Tdp1-DNA complex for its active site to
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access the phosphoamide bond to be cleaved. Patients who are affected by the SCAN1
disease develop neurodegenerative symptoms during their teenage years (Takashima et
al., 2002). The disease is completely recessive and heterozygous individuals remain
symptom free. Based on the data provided by Interthal and colleagues, we can conclude
that any H493R covalent complexes that accumulate in heterozygous individuals are
repaired by wild-type Tdp1 and this likely accounts for the recessive nature of the
SCAN1 defect.
But why might the pathology of SCAN1 be restricted to neurons? One possibility
is that elevated oxidative stress in post-mitotic neurons creates a particularly high level of
SSBs. In addition, the limited regenerative capacity of the nervous system might render
this tissue particularly susceptible to cell loss, where as cell loss from tissues with greater
regenerative capacity might be better tolerated. Another possibility might be that
unrepaired SSBs can be processed by homologous recombination in proliferating cells,
even in the absence of DNA replication, as in budding yeast. Consistent with this idea
was observation by El-Khamisy et al. (2005) that HR-defective XRCC3-/- chicken DT40
cells accumulated high levels of replication-dependent strand breaks during treatement
with CPT, confirming that HR repairs replication-associated DSBs in higher eukaryotes.
They also observed that there was an increased frequency of spontaneous sister chromatid
exchanges and an additional increase in these events in SCAN1 cells after exposure to
CPT concentrations too low to trigger the exchanges in normal cells, suggesting that HR
is indeed elevated in SCAN1 cells. Finally, it is possible that Tdp1 has additional, unique
functions in neurons distinct from its DNA repair activities. It is also interesting to note
that, based on clinical features, brain imaging and limited neuropathological studies, the
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most susceptible neurons in ataxia with oculomotor apraxia (AOA1), AOA type 2, and
presumably SCAN1 seem to include large, highly metabolic neurons, such as cerebellar
Purkinje cells, motor neurons, and dorsal root ganglia. AOA1 cells are sensitive to
hydrogen peroxide and harbor a mutation in aprataxin; a protein that interacts with
XRCC1 (Mossesso et al., 2005). AOA2 is caused by mutations in senataxin; a protein
that likely functions in RNA processing and transcription-coupled DNA repair (Ursic et
al., 2004). RNA interference (RNAi) technology can also be harnessed to reduce Tdp1
levels in cultured neurons and in vivo. Viral-mediated RNAi knockdown in the
cerebellum versus other brain regions could address regional susceptibility. If Tdp1deficient neurons are shown to accumulate SSBs, it will be critically important to
determine whether this genotoxic stress induces a DNA damage response or alters the
neuronal transcriptome, as one might predict with these results. Another important line of
inquiry will be to determine whether the AOA1 disease protein aprataxin, ties into Tdp1dependent processes due to its link with SSBR. While the connection of the AOA2
disease protein senataxin is less well established, its predicted involvement both in RNA
processing and in transcription-coupled repair further suggests intriguing links between
DNA repair and transcription in neurodegeneration.
Nevertheless, a role for PG-terminated DSBs in SCAN1 pathology cannot be
excluded. In cycling wild type yeast and mammalian cells, cell death induced by abortive
topo1 strand breaks appears to result largely, if not entirely, from DSBs arising at
replication forks (Vance et al, 2002 and Pouliot et al, 2001). In addition, mutation of
genes required for homologous recombination, a process that is essential for repairing
DSBs at collapsed replication forks, confers high levels of sensitivity to camptothecin in
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both yeast (Vance et al., 2002) and mammalian cells (Caldecott et al., 1991). Consistent
with these observations, in budding yeast Tdp1 appears to operate in concert with
homologous recombination specifically at topo1-DSBs associated with replication. The
neuronal apoptosis seen in knockout mice lacking critical DNA end-joining proteins,
such as XRCC4 and DNA ligase IV (Gao et al., 1998 and Barnes et al., 1998), suggest
that in the absence of DSB repair terminally differentiating neurons accumulate sufficient
DSBs to produce significant neurological pathology. There is evidence that at least some
of these ‘spontaneous’ DSBs reflect damage by oxygen free radicals associated with
normal oxidative metabolism (Karanjawala et al., 2003). For Friedreich ataxia (FA) and
other ataxias in which oxidative stress is considered to be an important pathogenic
element, damage to DNA (including but not limited to SSBs) and subsequent
transcriptional alterations could prove to be an important downstream consequence of
oxidative stress. FA is associated with a mutant frataxin protein, which leads to increased
oxidative stress due to a defect in iron homeostasis (Lodi et al., 2002 and Schulz et al.,
2003). Remarkably, FA shares some of the same neuropathological hallmarks with
SCAN1, including degenration of posterior columns and dorsal root ganglia. Thus, while
most recent papers imply a role of SSBR in SCAN1 cells, several lines of circumstantial
evidence also suggest a possible linkage among Tdp1 deficiency, oxidative damage,
DSBs and cerebellar ataxia. Even though lymphoblastoid cell lines derived from SCAN1
patients show at most only mild radiosensitivity (Zhou et al., 2005), it is possible that
endogenous tissues of SCAN1 patients are more sensitive to free radical damage than the
cell lines. Because cultured cells are subjected to higher oxygen tensions than would
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occur in vivo, they may be more likely to adapt to Tdp1 deficiency, for example, by
upregulating alternative pathways for repair of DSBs and other oxidative damage.
Clinical significance
Elucidating the mechanism of NHEJ is integral to understanding how normal cells
can avoid oncogenic transformation when challenged with the DNA DSB lesions, but
also for exploiting this pathway for cancer therapeutics. With the advent of gene therapy,
it may be possible to prevent carcinogenesis and hypersensitivity to radiation in patients
who have been diagnosed with any of the NHEJ gene deficiency. It is a well-known fact
that many tumors that are amenable to treatment by either chemotherapy or radiotherapy
become resistant to treatment after a period of time. Recurrence of the tumor after going
into remission is also a major challenge faced today in the treatment protocols of
certaincancers. Majority of the drugs or other modalities of treatment concentrate on
causing DNA damage to an extent that renders cells incapable of survival. However, very
few drugs target proteins involved in the repair of these DNA breaks. NHEJ is now a
well-established mode of DSB repair in vertebrate cells that involves Ku, DNA-PK and
XRCC4/DNA ligase IV as the key players in addition to others like Artemis and DNA
polymerase. Also, a role for Tdp1 in NHEJ repair cannot be completely excluded at this
point. What is the contribution of the NHEJ process and the proteins involved in this
process in the development of resistance by a tumor or recurrence of a tumor? It is
possible that a cancerous cell has elevated levels of these repair factors that enable the
cell to survive in spite of treatment and also contribute to recurrence. A robust repair
system can attenuate response to treatment. Knowing what proteins play a crucial role in
such repair systems and their structure and function will aid in the development of
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specific and potent inhibitors of these proteins. For example, LY294002, IC87361 and
wortmanin are well known inhibitors of DNA-PK and completely abolish end-joining.
Sodium ortho-vanadate is the only known inhibitor of Tdp1 (Davies et al., 2002). Such
specific inhibitors can be combined with conventional chemotherapeutic agents to
enhance the latter’s effectiveness as cytotoxic agents. This can be of an added advantage
in that it can also help in reducing the toxic effects associated with high doses of
chemotherapy. While inhibition of Tdp1 may not confer radiosensitivity, it would likely
confer sensitivity to topoI-mediated agents such as camptothecin. However, it will be first
necessary to develop inhibitors that are more specific to these proteins, before the
feasibility of this approach can be tested.
Molecular diagnostics is a rapidly advancing field in which insights into disease
mechanisms are being elucidated by use of new gene-based biomarkers. Until recently,
diagnostic and prognostic assessment of diseased tissues and tumors relied heavily on
indirect indicators that permitted only general classifications into broad histologic or
morphologic subtypes and did not take into account the alterations in individual gene
expression. Global expression analysis using microarrays now allows for simultaneous
interrogation of the expression of thousands of genes in a high-throughput fashion and
offers unprecedented opportunities to obtain molecular signatures of the state of activity
of diseased cells and patient samples. Microarray analysis may provide invaluable
information on disease pathology, progression, resistance to treatment, and response to
cellular microenvironments and ultimately may lead to improved early diagnosis and
innovative therapeutic approaches for cancer. Development of new molecular markers as
diagnostic probes has revolutionzed the detection methods for certain cancers in their
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very early stages. For example, p63, a homologue of the tumor suppressor gene p53, is
now known to be a useful marker for clinically undetectable but ultrasound suspected
prostate cancers. The discovery of SCAN1 gives rise to the important question as to what
cancers, if any, may have increased or decreased levels of this protein. If the level of
Tdp1 is found to be significantly altered in any of the cancers, then it can serve as a
useful tool in their detection. This technology also has many potential commercial uses
including: a method for screening camptothecin analogues or other compounds for their
resistance to repair by Tdp1 or to prescreen patients for their sensitivity to topisomerase
inhibitors which could identify patients most likely to respond to camptothecin therapy.
Further, it also provides for a vector comprising of the nucleic acid molecule for TDP1 as
well as the method of altering the level of TDP1 in a cell, a tissue, an organ or an
organism. Another possibility is that cells, particularly neurons wuth lower than normal
levels of Tdp1 may be more susceptible to oxidative DNA damage. Molecular
diagnostics may identify individuals with such partial Tdp1 deficiency as candidates for
anti-oxidant preventive therapies.
In conclusion, the identification of Tdp1 adds a new level of complexity to the
field of DNA DSB repair. Though our data conclusively shows that Tdp1 is capable of
removing PGs from DNA DSBs, we could not find any proof of its interaction with any
of the protein machinery of NHEJ repair pathway. Studying the gentypic and phenotypic
characteristics of tdp1-/- knockout mice in comparison with wild-type mice will unveil
important information as to the exact role of Tdp1 in repair of free radical mediated DNA
DSBs. If such a role were determined, it would contribute significantly towards making it
a prime target for chemotherapy, radiotherapy or a combination of both.

List of References

Abraham RT.Cell cycle checkpoint signaling though the ATM and ATR kinases, Genes
Dm., 1 5 2 177-2196 (2001)
Anderson CW and Lees-Miller SP. The nuclear serindthreonineprotein kinme DNA-PK.
Cn't. Rev. Eukalyot. Gene Expr., 2,283-3 14 (1 992)
Bannister AJ,Gottlieb TM,K o d d e s T,Jackson SP.c-Jun is phosphorylated by the
DNA-dependent protein kinase in vitro; definition of the minimal kinase recognition
motif. Nucleic Acids Res. 21:1289-95 (19933

Bai Y, Symington LS.A Rad52 homolog is required for RAD51-independent mitotic
recombination in Saccharomyces cerevisiae. Genes Dm. 10,2025-37 (1 996)

Bartheha I-TrJ, E l a h e y e r M, Christensen MO,Mielke C,Interthal H,Poulioi JJ,
Boege P, M a t h D. TDP1 ovecexpression in human cells wunteracts DNA damage
mediated by topoisomerases I and II. J Biol Chem. 279,5 56 18-25 (2004)
Baumann P,West SC. DNA end-joiningcatalyzed by human cell-free extracts. Proc Mat1
Acad Sci U S A. 95,14066-70 (1 998)
B a t e i n C, Bemstein H,Bayne CM and Garewal H. DNA repairfpapoptotic dual-role
proteins in five major DNA repair pathways: fail-safeprotection against carcinogenesis.
Mufut, Res., 511,145-178 (2002)
Blier PR, Griffith AJ, CraR J, Hardin JA Binding of Ku protein to DNA. Measurement
of affinity for ends and demonstration of binding to nicks. J B i d Chem. 268,7594-60 1
(1993)

Bryant PE.Enzymatic restriction ofmammalian cell DNA. evidence for doubllsstrand
breaks as potmtially lethal lesions. Int 3 Radiat Biol Relat Stud Phys Chem Med. 455560 (1985)
Burma S, Chen BP, Murphy M, Kurirnasa A, Chen DJ. ATM phosphorylates histone
H2AX in response to DNA double-strand breaks. JBiol Chem. 276:42462-7 (2001)

Caldecott KWProtein-protein interactions during mammalian DNA single-strand break
repair. Biochem Soc Trans.31,247-5 1 (2003)

Caldecott KW. DNA singlestrand break repair and spinowebellar ataxia. Cell. 112,710 (2003)

Callebaut I, Momon SP. From BRCAl to RAP I : a widespread BRCT module closely
associated with DNA repair. FEBS Lett. 400,2530 (1 997)
Carter T,Vancurova I;,

Sun I, h u W,k b n S. A DNA-activated protein kinase from
HeZa cell nuclei. Mol Cell B i d . 10,6460-71 (1 990)
Gary M ,Petenon SR, Wmg J, Bear DG,Bradbury EM,Chen DJ.DNA looping by Ku
and the DNA-dependent protein kinase. Proc Natl Acad Sci US A. 94:4267-72 ('1997)
Cae QP,Pit3 S,Leszyk J, Baril EF.DNA-dependent ATPase from BeLa cells is related to
human Ku autoantigen. Biochemistry. 33,8548-57 (1 994)

Chan DW and Lees-Miller SP.The DNA-dependent protein kinase is inactivated by
autophosphwylatian of the catalyhc subunit. J. Bid. Chem,271,8936-894 1 (1 996)
Chaudhry, M.A, Dedon, P.C., Wilson, D. M., Demple, B., and Weinfeld, M. Removal
by lrumatl apurinidapyrimidinicendonuclease 1 (Ape 1) and Escherichia coli
exonuclease ZFT of 3"phosphoglyc61ates h r n DNA treated with nmmzinostatin,
calicheanicin, and gamma-radiation. Biochem. Phamcel. 57,53 1-538 (1 999)
Chen X,Kinoshita K, Honjo T.Variable deletion and duplication at recombination
junction ends: implication for staggered double-strand cleavage in class-switch
recombination Proc Natl Acad Sci U S A. 98,13860-5 (200 1 )
Chmg TJ,Rey PG,Poon T,Kan CC.Kinetic studies of human tyrosyl-DNA
phosphcdiesterase, an enzyme in the topoisomeraseI DNA repair pathway. Eur d
Bimhem. 269,3697-704 (2002)

ConneHy JC,Leach DR.Repair ofDNA covalently linked to protein. Mol Cell. 13,30716 (2004)

Critchlow SE, Jackson SP,DNA end-joining: from yeast to man.Trends Biochem Sci. 23,
394-8 (1998)
D a s h GK, Lin SC, Zhao S, Sung P, Tomkinson A and Lee EY. DNA damags-indud
cell cycle checkpoints and DNA strand break repair in deveEopment and
tumorigenesis.Oncogene, 18,7883-7899 (1999)
Davies DR, lnterthal H, Charnpoux JJ, Hol WG.Expiorations of peptide and
oligonucleotidebinding sites of tyrosyl-DNA phosphodiaterase using vanadate
complexes. Med Chem. 47,829-37 (2004)
Davies DR, InterthaI H, Champoux JJ, Ho1 WG.The crystal structure of human tp~sylDNA phosphdiesterase, Tdp1. Stmchre. 10,237 4 8 (2002)

h d o p J, Morin X,Corominas M, Serras F, Tear G.glaikit is essential for the formation
of epithelial polarity and neuronal development. Curr Bid. 14,2039-45 (2004)

DiBiase SJ, Z a g ZC, Chen R, Hyslop T, Cusran WJ Jr, fliakis G. DNA-dependent
protein kinase stimulates an independently active, nonhomologous, end-joining
apparatus. Cancer Rm. 60,1245-53 (2000)

J3izdmglu M, Bergtold DS.Characterization of free radical-indud base damage in
DNA at biologically relevant levels. Anal Biochem. 156:182-8 (1986)
Downs JA, L o d e s NF, Jackson SP. A role for Saccharomyces cerevisiae histone H2A
in DNA repair. Nature. 408: 1001-4 (2000)

-her
D d Jackson SP.DNA-PK, ATM and ATR as sensors of DNA damage:
variations on a theme? Cum. Opin. Celt Bioi., 13,225-23 1 (200 1)
Dvir A, Peterson SR,Knuth MW, Lu H, Dynan WS.Ku autoantigen is the regulatory
component of a templateassociated protein kinase that phosphorylates RNA polymerase
II.Proc Nat2 Acad Sci US A. 89,11920-4 (1 992)
Elliott B md Jasin M. Doublestrand breaks and translocations in cancer. Cell. Mol, Lye
Sci.,59,373-385 (2002)
El-Khamisy SF,Saifi GM,Weinfeld M, Johansson F,HelZeday T,Lupski JR, Cddecott
KW. Ddective DNA single-strand break repair in spinocerebellar ataxia with axonal
neuropathy-1 .Nature. 434,108- 13 (2005)
Essers I, Hendriks RW,Swagemakers SM,Troelstra C, de Wit J, Bootma D,
Hoeijmakers JH, K a n w R.Disruption of mouse RAD54 reduces ionizing radiation
resistance and homologous recombination. Cell. 1997 89,195-204 (1 997)
Essers J, van Steeg H,de Wit J, Swagemakers SM,Vermeij M,Hoeijmakers M, Manaar
R Homologous and non-homologous remnbination differentially affect DNA damage
repair in mice. EMBO J 19,1703- 10 (2000)

Erixon K, Cedewall B. Linear induction of DNA doublestrand breakage with X-ray
dose, as determined h n DNA fragment size distribution. Radiat Res. 142,153-62 (1 995)
F. Liang, M. E b , P.J. Romanieho and M. Jasin, Homology-directedrepair is a major
double-strand break repair pathway in mammalian cells. Proc, Natl. Acad. Sci. US.A. 95,
5172-5177 (1998)

Fdck J, Mailand N,Syljuasen RG,Bartek J, Lukas J. The AIM-CW-Cdc25A
checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410,842-7
(2001)

Falzon M, Fewell JW, Kuff EL. EBP-80, a transcription factor closely resembling the
human autoantigen Ku,recognizes single- to double-strand transitions in DNA JBiol
Chem 268,10546-52 (1 993)

Feldrnann E, S c h i m m n V, Goedecke W,Reichenberger S, Pfeiffer P. DNA double
strand break repair in cell-& extracts h m Ku80-deficient cells: implications for Ku
serving as an alignment factor in non-homologousDNA end joining,Nucleic Acidr Res.,
28,2585-96 (2000)

Fisher TL,Terhorst T, Cao X, Wagner RW. Intracellular disposition and metabolism of
fluorescent1y-labeled unmodified md modified oligonucleotides microinjected into
mammalian cells.Nucleic Acids Res., 21,3857-65 (1993)
Game JC.DNA doublestrand breaks and the R.AD50-RAD57 genes in Saccharomyces.
Sernin Cancer Biol. 4,7343 (1 993)

Giloni L, Takeshita M, Johnson F, Iden C,Grolhan AP. Bleomycin-indud strandscission ofDNA. Mechanism of deoxyribose cleavage. JBiol Chem. 256,8608- 15 (1 98 1)
Goto S, Watanabe M, Yatagai F. Delayed cell cycle progression in human

lymphoblastoid cells after expowe to high-LET radiation melates with extremely
localized DNA damage. Radiat Res. 158,678-86 (2002)
Gottlieb TM,Jackson SP.The DNAdependent protein kinase: requirement for DNA
ends and association with Ku antigen. Cell. 72,13 1-42 (1993)
Gradzka I, Buraczewska I, Kuduk-Jaworska J, Romaniewska A, S m i e l I.
Radiosensitizing properties of novel bydroxydicnrboxylatop1atin~~(~
complexes with
high or low reactivity with thiols: two modes of action. Chem Biol Interact, 146,165-77
(2M3)

Haber JE.Partners and pathways repairing a doublsstrand break. TrentJlF Genet., 16,
259-264 (2000)
Hammarsten 0,
DeFazio LG, Chu G.Activation of DNAdependent protein kinase by
single-strandedDNA ends. J Bid Chem, 275, 1541-50 (2000)
Hartley KO,Gel1 D,Smith GC,Zhang H,IDivecha N, Connelly MA, A h o n A, b s Miller SP,Anderson CW, Jackson SP.DNA-dependent protein kinase catalytic subunit: a
relative of phosphatidylinositol3-kinase and the ataxia telangiectasia gene product. Cell.
82,849-56 (1 995)

H a i e MS, Kurimnsa A, Burma S, Menissier-de Murcia J, de Murcia G,Li GC,Chen
DJ. Lethality in PAW- 1Ku80 double mutant mice reveals physiologicd synergy during
early embryogenesis. DNA Repair (Amst). 2,15 1 -8 (2003)

Hoeijmakers JH. From xeroderma pigmentosum to the biological clock contributions of
Dirk Bootsma to human genetics. Mutat Res. 485,43-59 (2001)
Hughes WE, Elgundi Z, Humg P,Frohman MA, Biden TJ. Phospholipase DI regulates
secretagogue-stimulated insulin release in pancreatic beta-cells. JBiol Chern. 279,2753441 (2004)

Hwneau Y, Vible N, Chasserot-Golaz S, hpont JIL, X)u G, F m h Mk, Bader MF,
Podain B. A role for phospholipase D 1 in neurotransmitter release. Proc Natl Acad Sci U
SA. 98, 15300-5 (2001)
Hutchinson F. Chemical changes induced in DNA by ionizing radiation. Prog Nucleic
Acid Res Mol Bid. 32,115-54(1985)

Inamdar KV, Pouliot JJ, Zhou T,',-Miller
SP,Rasouli-NiaA, Povirk LF.Conversion
of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks
by the human tyrosyl-DNA phosphodiesterase hTdpl -1Biol Chem. 271,27162-8(2002)
I n t d H, Pouliot JJ, Champow JJ. The tyrosyl-DNA phosphodiesterase Tdpl is a
member of the phospholipase D superfamily. Proc Natl Acad Sci U 5 A. 98,12009-14
(20013

lvanov EL, Sugawara N,Fishman-hbell J, Haber JE. Genetic requirements for the
singlestrand annealing pathway of doublestrand break repair in Saccharomyces
cerevisiae. Genetics. 142,693-704(1996)

Izzard RA, Jackson SP,Smith GC. Competitive and noncompetitive inhibition of the
DNA-dependent protein finase. Cancer Res. 59,258 1-6 (1 999)
J.E. Haber, Parhem and pathways repairing a double-strand break. Trends Genet. 16,
259-264(2000)

Jackson SP.Dekthg, signalling and repairing DNA double-strand breaks. Biochem
Soc. Tram, 29,655-661(2001)

Jackson SP and Jeggo PA. DNA double-strand break repair and V@)J recombination:
involvement of DNA-PK. Trends Biochem. Sci., 20,412-4 1 5 (1995)
Jilani A, Rmotar D, Slack C, Ong 6 ,Yang XM, Scherer SW, Lasko DD. Molecular
cloning of the human gene, PNKP, encoding a polynucleotidekinase 3'-phosphatase and
evidence for its role in repair of DNA strand breaks caused by oxidative damage. J B i d
Chem 274,24 176-86 (1 999)

Johnson RD and Jasin M. Sister chromatid gene convmion is a prominent double-strand
break repair pathway in mammalian cells. EMBO J ,19,3398-3407 (2000)

K a n a R Hoeijmakers JH and van Gent DC.Molecular mechanisms of DNA double
strand break repair. Trends Cell Biol., 8,483-489 (1 998)

Kwimi-Busheri F, Ddy G, Robins P, Canas B, Pappin DJ,Sgoums J, Miller GG,Fakhrai
H, Davis EM, Ze Beau MM, WeinfeId M. Molecular characterization of a human DNA
kinase. JBiol Chem 274,24187-94(I 999)

Kim ST,Lim DS,Canman CE and Kastan MB.Substrate specificitiesand identification
of putative substrates of ATM kinase family members. J. Biol. Chem,,274,37538-37543
(1999)
Labhart P.Nonhomologous DNA a d joining in cell-freesystems. E w JBiochem 265,
849-61 (1 999)
h k e y M,
Earnshaw WC.Nucleosome assembly.Nature. 286,763-7(1980)

See JW,Inamdar KV, Harrnah ME, Lees-Miller SP, Povirk LF.DNA end sequestration
by DNA-dependent protein kinase and end joining of stericdly constrained substrates in
wholecell extracts. Environ Mol Mutagen. 42,279-87 (2004)
Lees-Miller SP,Chen YR and Anderson CW. Human cells contain a DNA-activated
protein k i n e that phosphorylates simian virus 40 T antigen, mouse p53, and the human
Ku autoantigen. Mol. Cell. Biol., 10,6472-6481 (1 990)

kber R, Wise TW, Mizuta R,Meek K. The XRCC4 gene product is a target for and
interacts with the DNA-dependent protein kinase. J Biol O e m . 273,1794-80 1 (1 998)
b g a u e r C, K k l e r KW, Vogelstein B. Genetic instabilities in human cancers. Nature.
396,643-9 (1998)

Li Z, Oteml T, Gaa Y, Cheng HL, Seed B, Stamato TD, Taccioli GE, Alt FW. The
XRCC4 gene encodes a novel protein involved in DNA doublestrand break repair and
V@)J recombination. Cell. 83,1079-89 (1995)

Lindahl T.Instability and decay of the primary structure of DNA. Nature. 362,709-1 5
(1993)

Lindahl T.Mmvtagenesidanti~cinogmesis2001: screening, methods and
biomarkers. Mutat Res. 496,l-4(2001)

Liu C,Podiot JJ, Nash HA. Repair of topofsomerase I covalent complexa in the absence
of the tyrosyl-DNA phosphodiesterase Tdpl . Pmc Natl Acnd Sci U SA. 99,14970-5
(2002)

Ziu C, Pouliot JJ, Nash HA. T h e role of TDPl fim budding yeast in the repair ofDNA
damage. DNA Repair (Amst). 3,593-601(2004)

La T,Pan Y,h o SY, Li C,Kohane I, Chan J, Yankner BA. Gene regulation and DNA
damage in the ageing human brain. Naturee,429,883-91 (2004)
Mannironi C,Bonner WM,Hatch CL.H2A.X. a hisistone isuprotein with a conserved Cterminal sequence, is encoded by a novel mRNA with both DNA replication type and
pol yA 3' processing signals. Nucleic Acids Res. 17,91 13-26 (1989)
Marintchev,A., Mullen,M.A., Maciejewski,M.W., Pan,B., Gryk,M. and M~1len~G.P.
Solution structure of the single-strand break repair protein XRCCl N-terminal domain.
Nature Stmet. Bio h ,6,88&893 (1 999)
Martensson S, Hammarsten 0.DNAdepmdent protein kinase catalytic subunit.
Structural requirements for kinase activation by DNA ends. JBioI Chem. 277,3020-9
(2002)

Mcflwraith MJ, Van Dyck E, Masson JY, Stasiak AZ, Stasiak A, West SC.
Reconstitution of the strand invasion step of double-strand break repair using human
Rad5 1 Rad52 and RPA proteins, J Mol Bid. 304,15 1-64 (2000)
Mimori T, A k i d M, Yamagata H, hada S, Yoshida S, Homma M. Characterization of
a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from
patients with polymyositis-sc2erOdmaoverlap. J Clin Invest. 68,6 11-20 (1 98 1)

Morrison C,Sonoda E, Takao N,Shinoka A, Yamamoto K and Takeda S, The
controlling role of AIXm in homologous recombinational repair of DNA damage. EMBQ
J., 19,463-471 (2000)
Norbury CJ and Hickson ID.Cellular responses to DNA damage. Amu. Rev. P h a m c o l .
Toxicol., 41,367-40 1 (200 1)

Obe G, Johmes C, Schulte-FmhlindeD. DNA double-strand breaks induced by sparsely
ionizing radiation and endonucleases as critical lesions for cdI death, chK>rnosomal
aberrations, mutations and oncogenic transformation Mutage~tais.7,3-12 (1992)
Ochern AE,Skopac D, Costa M, Rabilloud T,Vuillard L, Simoncsits A, Giacca M,
Palaschi A. Functional properties of the separate subunits of human DNA helicase II/Xu
autoantigen. J Biol Chem, 272,299 19-26 ( 1997)

Ohya T,Kawasaki Y,Hiraga S, Kanbara S, Nakajo K, Nakashima N, Suzuki A, Sugino
A. The DNA plymeme domain of pol(epsi1on) is required for rapid, efficient, and
highly amrate c h r o m o m d DNA replication, telomere Zen@ maintenance, and normal
cell senescence in Saccharomyces cerevisiae, JBioI Chem. 27,728099- 1 08 (2002)

Pate1 KJ, Y u VP,Lee H, Corcoran A, Thistlethwaite FC, Evans W, Colledge WH,
Friedman LS,Ponder B A, Venkitaraman AR. Involvement of B d in DNA repair. Mol
Cell. 1,347-57 (1998)

Pastink A, Eeken JC,Lohman PH. Genomic integrity and the q a i r of doublestrand
DNA breaks. Mutat Res. 480-481,37-50 (2001)

P.Wang, R.H. nou, Y.Zou, C.K. Jackson-Cook and L.F. Povirk, Highly conservative
reciprocal translocations formed by apparentjoining of exchanged DNA double-strand
break ends. Pmc. Nutl. Acad. Sci. Lr.S.A. 94,120 18-1 2023 (1997)
Pastwa E, Blasiak J. Non-homo'logous DNA end joining. Acta Biochim Pol.; 50,89 1-908
(2003)
Paul1 TT and Gellert M. The 3' to 5' exonuclease activity of Me- 11 facilitates repair of
DNA double-strand breaks. Mol. Cell, 1,969-979 (1 998)

Pfeiffer P, Goedecke W, Obe G.Mechanisms of DNA double-strand break repair and
their potential to induce chromosomal aberrations. Mufagenesis.15,289-302 (2000)
Pierce AJ, Stask JM, h u j o FD,Moynahan ME, Berwick M, Jasin M. Double-strand
breaks arrd tumorigenesis. Trends Cell Bid. 11, S52-9 (2001)
Plo I, Liao ZY, B m l o SM, Kohlhagen G, Caldecott KW, Weinfeld M, Pommier Y.
Association of XRCC l and t p s y l DNA phosphdiesterase (Tdpl ) for the repair of
topoisomerase I-mediated DNA lesions. DNA Repair (Amt),2,1087-1 00 (2003)

Pommier Y. Camptothecins and topoisomerase I: a foot in the door. Targeting the
genome beyond topoisomerase I with mnptothecins and novel anticancer drugs:
importance of DNA replication, repair and cell cycle checkpoints. Cum Med Chem
Anticancer Agenk 4,429-34 (2004)
Pouliot JJ, Robertson CA, Nash HA. Pathways for repair of topoisomerase I covalent
complexes in Sacchmmyces wevisiae. Genes C&. 6,677-87 (2001)
Pouliot JJ, Yao KC, Robwbun CA, Nash H A Yeast gene for a Tyr-DNA
phosphodiesterase that repairs topoisomerase I wmpIexes. Science. 286,552-5 (1 999)

Povirk W. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents:
bleomycin, neocaninostatin and other enediynes. Mutat Res. 355,7149 (1996)

Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham P1,Ashendel C, Zalkow
L, Matter WF, Dodge J, Grindey G.Wortrnannin as a unique probe for an intraellular
signalling protein, phosphoinositide 3-kinase. Cancer Res. 54,24 19-23 (1 994)
Raymond AC, Rideout MC,Staker B,Hjlerrild K, B-n AB Jr. Analysis of human
tyrosyl-DNA phosphdiesterase I catalytic residues. J Mol BioE. 33 8,895-906 (2004)

Raymond WE, Klsckner N.Expression of the Sacchmmyces cerevisiae W S O gene
during meiosis: steady-state h?lnscript levels rise and fall while steady-state protein levels
remain constant. Mol Gen Genet. 238,390-400(1 993)

Rideout MC, Raymond AC, Burgin AB Jr. Design and synthesis of fluorescent substrates
for human tyrosyl-DNA phosphdiesterase I. Nucleic Acids Res. 32,4657-64 (2004)

Rogakou EP,Pilch DR, Orr AH, Ivanova VS,Bonner WM. DNA double-strandedbreaks
induce histone MAX phosphorylation on serine 139. J Biol Chem 273,5858-68 (2998)
Roth DB,Porter TN, Wilson JH.Mechanisms of nonhomologous recombination in
mammalian cells. MoE Cell B i d 5,2599-607 (1985)
Rosenzweig KE, Youmell MB,Palayoor ST,Price BD.Radiosensitization of human
tumor cells by the phosphatidylinosiltol3-kinaseinhibitors wortmannin and LY294002
correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Clin Cancer Res. 3,1149-56 (1 997)
Santoro MM, Gaudino G,Villa-Moruzzi E. Protein phosphatase 1 binds to phospho-Ser1 394 of the macrophage-stimulating protein receptor. Biochem J., 376,587-94 (2003)

Scully R, Chen J, Ochs RL,Keegan K, Hoekstra M,Feunteun J, Livingston DM.
Dynamic changes of BRCAl subnuclear location and phosphorylation state are initiated
by DNA damage. Cell. 90,425-3 5 (1997)

Shinohara A, Ogawa H, Ogawa T.Rad5 1 protein involved in repair and recombination in
S.cerevisiae is a RecA-like protein Cell. 69,457-70 (1992)
Sibanda BL,CTitchlow SE, Begun J, Pei XY,Jackson SP,Blundell TL,Pellegrini L.
Crystal structure of an Xrcc4-DNA l i m e IV complex. Nat Struct Biol. 8,110 15-9 (2001)
Smith GC, Jackson SP. The DNA-dependent protein kinase. Genes Dm., 13,9 16-34
(1999)

Steigher RJ, Povirk LF.Bleomycin-inducedDNA lesions at mutational hot spots:
implications for the mechanism of double-strandcleavage. Pmc NatL Acad Sci US A;
87,8350-4 (1990)
Sugiyarna T,Zaitseva EM, Kowalczykowski SC. A single-strandedDNA-binding protein
is needed for efficient presynaptic complex formation by the Sacchammyces cerevisiae
Rad51 protein. J Biol Chem. 272,7940-5 (1997)

Suh, D., Wilson III,D.M., and Povirk, L. F.3'-phosphodiesteraseactivity of human
apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res.
25,2495-2500 (1997)
Sung P. Catalysis of ATF-dependent homologous DNA pairing and strand exchange by
p i RAD5 1 protein. Science. 265,124 1-3 (1994)

Takashima H, Boerkoel CF, John J, Saifi GM, Salih MA, Armstrong D, Mao Y, Quiocho
FA, Roa BB, Nabgawa M, Stockton DW, Lupski JR. Mutation of TDP 1, e n d i n g a
topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with
axonal newopathy. Nut Genet. 32,267-72 (2002)
Takata M, Sas& MS,Sonoda E, Morrison C, Washimoto M, Ufsumi H,Yamaguchi-Iwai
Y,Shinohara A and Takeda S. Homologous recombination and non-homologous end-joining
pathways of DNA double-strand break repair have overlapping roles in the maintenance of
chromosomal integrity in vertebrate cells. EMBO J , 17, 5497-5508(1998)
Taylor,R.M.,Moore,D.J., WtehouseJ., Johnso@. and Caldscott,KW. A cell cyclespecific requirement for the XRCCI BRCT II domain during mammalian DNA strand
break repair. MoI. Cell. Biol., 20,735-740 (2000)
Thompson,L.H., BrookmanJLW., Jones,N.J., Allen,S.A. and Carrano,A.V. Molecular
cloning of the hman m C C I gene, which muects defective DNA strand break repair
and sister chromatid exchange. Mol. Cell. Biol., 10,6 16 0 4 1 7 1 (1 990)
Thompson LH and Schild D.Recombinational DNA repair and human disease. Mutat.
Res., 509,49-78 (2002)

Thompson,LH. md West;M.G. XRCC 1 keeps DNA from getting stranded. Mutcat. Res.,
459,1-18 (2000)
Tuteja N, Tuteja R,Ochem A, Taneja P, H w g NW, Simoncsits A, Susic S,Rahman K,
Marusic L, Chen J. Humm DNA helicase II: a novel DNA unwinding enzyme identified
as the Ku autoantigen EMBO J. 13,4991-5001 (1994)
Ui M, Okada T,Hazek K, Hazelci 0.Wortmannin as a unique probe for m intracellular
signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci. 20,303-7(1995)
Vance JR, Wilson TE.Yeast Tdpl and Radl-RadlO function as redundant pathways for
repairing Top1 replicative damage. Proc Natl Acad Sci USA. W,13669-74 (2002)

V m n R,Vissinga C,Platzer M, Cerosdetti KM, Chrtanowska KH, Saar K, B e c b m
G, Seemanova E, Cooper PR, Now& NI, Stumm M, Weemaes CM,Gatti M,
Wilson
RK, Digweed M, RosenthaI A, Spaling K, Concannon P,Reis A. Nibrin, a novel DNA
double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 93,
467-76 (1 998)

Vogelstein B,Kinzler KW.The multistep nature ofcancer. Trends Genet., 9,13 8-4 1
(1993).

Waldmm TA,Misiti J, Nelson DL, kaemer KH. Ataxia-telangiectasis: a multisystem
hereditaxy disease with imunodeficiency, impaired organ maturation, x-ray
h ~ m s i t i ~ tand
y , a high incidence of neoplasia. Ann Intern Med. 99,367-79 (1 983)
Walker JR,Corpina RA, GoIdberg J. Structure of the Ku heterodimer bound to DNA and
its implications for double-strand break repair. Nature. 412,607- 14 (200 1)
Wang P, Zhou RH, Zou Y,Jackson-Cook CK, Povirk LF.Highly conservative reciprocal
translocations formed by apparent joining of exchanged DNA double-strand break ends.
Proc hratl Acad Sci US A. 94,1201 8-23 (1997)
Wang S,Ouo M, Oclyang W, U X, Cordon-Cardo C, Kurimasa A, Chen DJ, Fuks 2,Ling
CC,Li GC.The catalytic subunit of DNA-dependent protein kinase sdectively regulates
p53-dependent apoptosis but not cell-cycle mest. Proc Narl Acad Sci U S A., 97, 1584-8

(2000)
Weinfeld M, Chaudhry MA, D&ow 23, Pelletier JD,Poirier GG,Povirk LF, LeesMiller SP. Interaction of DNA-depencEmt protein kinase and poly(ADP-ribose)
polymerase with radiation-induced DNA strand breaks. Radial Res. 148,22-8 (1997)

Williams CJ,Grandal I, Vesprini DS,Wojtyra LJ,Danska SS,Guidos CJ. hadiation
promotes V@)J joining and RAG-dependentneoplastic transformation in S C D T-cell
precursors. :Mol C d BioS; 21,400-13 (2001)

Wu X, Lieber MR Protein-proteinand protein-DNA interaction regions within the DNA
end-binding protein Ku70-Ku86.Mol Cell B i d . 16,5 1 86-93 (1996)

Yaneva M, Kowalewski T,Lieber MR. Interaction of DNA-dependent protein kinase
with DNA and with Ku:biochemical and atomic-force microscopy studies. EMBO J. 16,
5098-1 12 (1997)
Yang, S. W.,Burgin, A. B.,Jr., Huizenga, B. N., Robahon, C.A., Yao, K. C., and Nash,
H. A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA
and type 1topoisomerases. Proc. Nafl.Acad. Sci, U. S.A. 93,11534-1 1539 (1 996)

Yannone SM, Roy S, Chan DW, Murphy hW,Humg S, Campisi J, Chen DJ, Werner
syndrome protein is regulated and phosphoqlatad by DNA-dependent protein kinase. J
Biol Chem. 276,38242-8 (2001)
Yoo S, Dynarr WS. Characterization of the RNA binding properties of Ku protein.
Biochemistry. 3 7,1336-43 (1998)

Haritha Tatavarthi was born on April 8th, 1 978 in Visakhapatnam, INDIA. She

received her undergraduate degree in Pharmacy from M.S. Ramaiah College of

Pharmacy, NDIA in 2000.

1. Presented a poster (Action of Tdpl on 3'-PG terminated Double strand
breaks) at the 23rd Annual Graduate Research Association of Students in

Pharmacy (GRASP) meeting held in Richmond in May, 2003
2. Presented a poster (Action of Tdpl on 3'-PG terminated Double strand breaks)
at the 19th Annual Watt's Day presentations held at the Medical College of

Virginia, Richmond in October, 2004

3. Presented a poster (Action of Tdpl on 3'-PG terminated Double strand breaks)
at the 2005 Annual American Assmiation for Cancer Research held in Anaheim,

California
4. Zhou T, Lee JW, Tawarthi W,Lupski JR, Valerie K, Povirk LF. Deficiency in
3'-phosphoglycolateprocessing in human cells with a hereditaq mutation in
tyrosyl-DNA phosphodiesterase (TQP 1). Nucleic Acids Res. 33,289-97 (2005)

